People

Mike Dutra is a senior managing director and senior investment officer in life sciences. He joined Hercules in June2014 after Goldman Sachs operations and DePuy Synthes quality work. He studied industrial engineering at Northeastern.

Randi joined Novo Holdings in March 2021 as accountant. Her main responsibilities are bookkeeping and payments to vendors. Prior to joining Novo Holdings Randi was employed by ISS World Services as accounting specialist for more than 7 years, and prior to this Randi spent more than 6 year in Nomeco as  accountant and financial controller. Randi holds first part of Business Administration (HD).

Rachel Weathered joined Novo Holdings in 2025 as an Associate on the Venture Investments team, based in Boston. Previously, Rachel was an Investment Analyst on the Global Equities team at UBS Asset Management, where she performed fundamental research on public biotech and life sciences companies to inform portfolio investments. Rachel holds a PhD in Molecular Engineering from the University of Chicago, with a focus in immunoengineering. She also holds a BS in Biomedical Engineering from Northwestern University.

Rafal Rybak joined Novo Holdings in March 2026 as Executive Assistant in Planetary Health, where he supports the Planetary Health Partners. Prior to joining Novo Holdings, Rafal worked as Executive Assistant at McKinsey & Company and Boston Consulting Group. Most recently, he served as Project Manager at Novo Nordisk. Rafal holds a Bachelor’s degree in Finance & International Business and a Master’s degree in Investment and Real Estate.

Philip joined Novo Holdings A/S in January 2025 as Digital Architect to align business processes and strategy with digital solutions to ensure Novo Holdings reaches its ambitions for digital transformation. Prior to joining Novo Holdings A/S, Philip worked as Lead Solution Architect at VML MAP with responsibility for architecting and implementing marketing automation solutions and products. Philip holds a BSc, MSc, and PhD in Enterprise Systems from Copenhagen Business School.

Thomas Harris is a senior managing director in Hercules’ technology group. His earlier career includes SVB syndications, technology investment banking at Bank of America and TD Securities. He studied finance at NYU and completed an MBA at Columbia.

Chairman of the Board, Biomason Board member warfair and Global Bio Fund Former President and CEO of Novozymes A/S

Peter joined Novo Holdings in February 2026 as a Risk Specialist, where he focuses on developing overarching risk management for Novo Holdings’ investments. Prior to joining Novo Holdings, Peter gained experience in public equity markets through Equity Research at SEB. He has also worked as a Data Engineering Consultant at Initiate, followed by a position in Quantitative Trading at Alipes Capital. Peter holds an MSc in Finance and Strategic Management from Copenhagen Business School

About Philippe Houssiau Belgian citizen Board positions Philippe has extensive board experience and currently serves on the boards of medneo, RAM Infotechnology, and Corilus. Career 2022 – Executive Chairman, medneo 2021 – Non-Executive Director, RAM Infotechnology 2020 –  Chairman of the Board, Corilus 2021 – 2023 Non-Executive Director, Mach7 Technologies 2021 – 2022 Non-Executive Chairman, Althea 2020 – 2021 Interim Chief Executive Officer, MAK-SYSTEM International Group 2019 – 2020 Chairman of the Board, Corepoint Health 2018 – 2020 Chairman of the Board, Rhapsody 2017 – 2020 Operating Partner, HgCapital 2015 – 2018 Chairman, 4ways 2013 – 2017 Vice President, General Manager Healthcare, DXC Technology 2010 – 2012 Group Chief Executive Officer, Alliance Medical Ltd 2009 – 2011 Chief Executive Officer, Telegentis NV 2002 – 2007 President, Healthcare Division, Agfa Gavaert Healthcare 1997 – 2002 Partner/Senior Partner, PwC 1994 – 1997 Director HR Europe, Raychem (now TE Connectivity) Education Philippe holds a degree in Chemical Engineering/Biotech and a BSc in Pharmaceutical Sciences, both from Vrije Universiteit Brussel.

Peter Lytje is listed by Novo Holdings as Head of Risk & Compliance in Finance & Operations. Further biography is not published on the reviewed profile.

Catherine Jhung originates technology and sustainability investments as a senior managing director. Her previous work includes Cleantech Group, edo Interactive and Equilar. She holds a Berkeley MBA and studied at UC Davis.

Spencer M. Wheeler, Jr. is currently Partner and Portfolio Manager, Sands Capital Horizons in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Guardian Point Capital (2012 - 2025) Charlottesville, VA | Partner The Fiduciary Group (2010 - 2012) Savannah, GA | Director of Research Cotton Hall Asset Management (2007 - 2008) New York, NY | Junior Analyst. Education: University of Virginia (2007) BS | McIntire School of Commerce.

Jamey Thompson is currently Partner and Portfolio Manager, Sands Capital Horizons in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): University of Virginia (2013 - Present) Charlottesville, VA | Department of Systems and Information Engineering Faculty Jocassee Quantitative, LLC (2021 - 2025) New York, NY and Charlottesville, VA | Managing Member Blackstone (2015 - 2020) New York, NY | Managing Director Citadel (2012 - 2013) Chicago, IL | Head of Quantitative Credit and Co-Head Global Credit Citadel (2008 - 2012) Chicago, IL | Senior Portfolio Manager King Street Capital Management, LLC (2005 - 2008) New York, NY | Trader. Education: Princeton University (2006) PhD | Operations Research and Financial Engineering Princeton University (2005) MA | Operations Research and Financial Engineering University of Virginia (2000) BS | Systems Engineering.

Morgan (Flagg) Fleites is currently Chief of Staff and Director, Client Advisory, Sands Capital Horizons in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Fry’s Path Capital (2021 - 2025) Charlottesville, VA | Senior Investment Associate Cambridge Associates (2016 - 2021) New York, NY | Senior Investment Associate. Education: Gettysburg College (2016) BA | Economics.

Joseph R. Andrasko is currently Chief Executive Officer and Chief Investment Officer, Sands Capital Horizons in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Fry’s Path Capital (2019 - 2025) Charlottesville, VA | Managing Partner UVA Darden School of Business (2015 - Present) Charlottesville, VA | Professor of Practice Murray Enterprises (2011 - 2019) Charlottesville, VA | Director of Investments Deloitte Consulting (2006 - 2008) Boston, MA | Analyst. Education: University of Virginia (2011) MBA | Darden School of Business Bowdoin College (2004) BA | Economics and Spanish.

Naji Zien Alabdin is currently Cybersecurity and Software Engineer in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): Sands Capital (2023 - 2025) Arlington, VA | Associate Software and Cybersecurity Support Engineer. Education: George Mason University (2023) BS | Cybersecurity Engineering.

Michele E. Wong is currently Legal Operations Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2026. Published career chronology (historical appointments): StartYourRecovery (2025 - 2026) Alexandria, VA | Communications Consultant Reingold Inc (2024 - 2025) Alexandria, VA | Communications Specialist Institute of International Education (2023 - 2024) Washington, D.C. | Communications & Project Coordinator OST, Inc. (2019 - 2022) McLean, VA | Payroll Clerk Ashburn Eyecare Associates (2018 - 2019) Ashburn, VA | Receptionist. Education: George Mason University (2025) Paralegal Certificate American University (2022) BA | Journalism.

Paloma joined Novo Holdings Asia in September 2022. Prior to Novo Holdings, Paloma worked with JP Morgan’s Healthcare Banking team in Hong Kong. Before this, she was an Investment Banking Associate with China Renaissance and Bank of America Merrill Lynch. Paloma holds a Bachelor of Business Administration from Fudan University, and a Master of Business of Business Administration from MIT Sloan School of Management.

Paul Ewing-Chow joined Novo Holdings Asia in April 2024 as Head of Corporate Affairs Asia. Prior to joining Novo Holdings, Paul was Managing Director of Public Relations, Branding and Communications at CBC Group, a healthcare-dedicated investment firm. He has also served at Temasek International as Director of Public Affairs and was previously with Standard Chartered Bank in various roles at the bank’s Singapore and Dubai offices. Paul holds a Bachelor of Communications from the Edith Cowan University in Australia.

Ola joined Novo Holdings in April 2025 as a Senior Associate in Capital Investments. He is responsible for analyzing direct investment opportunities in the credit markets and managing partnerships with external managers. Prior to joining Novo Holdings, Ola spent four years at Nordea in the Leveraged Finance team, focusing on leveraged buyouts and the financing of private equity transactions. He holds an MSc in Applied Economics and Finance from Copenhagen Business School and a BSc in Business Administration from the University of Tromsø.

Member of the Novo Holdings Board since 2025. Member of the Novo Holdings Audit Committee. Narv Narvekar was born in 1962 in Washington D.C. and is a US national. Narv has a long and distinguished career leading investment organizations. Since 2017, he has served as CEO of Harvard Management Company (“HMC”). At HMC, he oversaw its successful restructuring and turnaround. Today he oversees the endowment and its portfolio, working closely with partners and colleagues.  Previously, he was CEO of Columbia University Investment Management Company for close to 15 years, running Columbia’s endowment. Prior, he was a Managing Director in the University of Pennsylvania Office of Investments. He began his career at JP Morgan where he worked for almost 15 years. Narv brings a long-term strategy and investment perspective from mission-driven organizations. Other Board Positions and Management Duties:   Advisory Board of McKinsey Investment Office “MIO” Advisory Board of ExB Group Advisory Board of Valence8

Steve Kuo leads Hercules’ technology investment group. His earlier career includes product management at silicon-photonics company Lightcross and investment work at Comdisco Ventures.

Julien Maquet is a financial analyst in the Q4 2024 WE Life Sciences roster, joined August 2024. Founded and sold a small company and studied biomedical sciences and biomedical data management, with programming, statistics and database skills. The dated public roster does not by itself establish a new employment start day or uninterrupted tenure through October 2026.

Gina Toussaint is currently Sr. Accountant in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2007. Published career chronology (historical appointments): Sands Capital (2012 - 2016) Arlington, VA | Staff Accountant Sands Capital (2007 - 2011) Arlington, VA | Accounting Assistant Sandy Spring Bank (2007) Olney, MD | Assistant VP for Vendor and Purchasing Cedars Medical Center (2005 - 2007) Miami, FL | Assistant Director for Ethics and Compliance. Education: Indiana University - Bloomington (2005) MS | Public Finance Administration.

Katie Tillotson is currently Corporate Accountant in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Northrop Grumman (2020 - 2025) Falls Church, VA | Senior Principal Financial Analyst Ernst & Young (2018 - 2020) Boston, MA | Audit Staff Cambridge Associates (2014 - 2017) Arlington, VA | Investment Operations Analyst. Education: University of North Carolina at Chapel Hill (2018) MA | Accounting University of Pittsburgh (2014) BS/BA | Economics and French.

Arthur Thomas IV is currently Sr. Full Stack Developer in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): Sands Capital (2019 - 2025) Arlington, VA | Full Stack Developer University of Maryland, the Graduate School (2017 - 2019) College Park, MD | Systems Analyst. Education: University of Maryland College Park (2018) Bachelors | Government & Politics.

Laura J. Stewart is currently Director, Office and Events Planning in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2007. Published career chronology (historical appointments): Sands Capital (2020 - 2022) Arlington, VA | Sr. Manager, Office and Events Planning Sands Capital (2012 - 2019) Arlington, VA | Office Manager Sands Capital (2007 - 2011) Arlington, VA | Administrative Assistant Hurd I/T (2006 - 2007) McLean, VA | Executive Assistant Mica (2003 - 2006) Fairfax, VA | Title/Settlement Officer. Education: University of North Carolina at Chapel Hill (2003) BA | Journalism and Mass Communication.

Matthew Steele is currently Director, Applied AI Solutions in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Data Analytics and Support Analyst Sands Capital (2020 - 2021) Arlington, VA | Data Analytics and Support Associate Thomson Reuters Special Services (2019 - 2020) McLean, VA | Data Engineer RiskSpan (2019 - 2019) Arlington, VA | Sr. Analyst RiskSpan (2018 - 2018) Arlington, VA | Analyst RiskSpan (2016 - 2017) Arlington, VA | Associate Analyst Mount St. Mary’s University (2015 - 2016) Emmitsburg, MD | Data Analyst. Education: Mount St. Mary’s University (2015) BS | Psychology.

Kristin N. Sizemore is currently Head of Human Resources in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2010. Published career chronology (historical appointments): Sands Capital (2010 - 2015) Arlington, VA | Director, Human Resources Folio Investing (2007 - 2010) McLean, VA | Director of Human Resources Information Management Consultants, Inc. (2000 - 2007) Reston, VA | Human Resources Supervisor. Education: The George Washington University (2005) MS | Organizational Management George Mason University (1998) BA | Sociology and English.

Akriti Shrestha is currently Business Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): Sands Capital Management (2022 - 2025)Arlington, VA | Business and Data Associate Sands Capital Management (2019 - 2021)Arlington, VA | Technology Coordinator Breakout Capital Finance, LLC (2017 - 2019)McLean, VA | Executive Assistant to the EVP and General Counsel, EVP and CTO, EVP and CFO Euro Stone Craft (2013 - 2017)Herndon, VA | Assistant Manager NetSec Meds, Inc. (2012 - 2013)Ashburn, VA | Administrative Assistant. Education: Strayer University (2017)BBA | Finance Northern Virginia Community College (2015)AS | Computer Science.

Avery L. Schober is currently Finance Manager in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2017. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Sr. Financial Analyst Sands Capital (2022 - 2023) Arlington, VA | Financial Analyst Sands Capital (2017 – 2021) Arlington, VA | Jr. Financial Analyst. Education: Sewanee - The University of the South (2017) BA | Economics and Mathematics.

Nigel Govett is Chief Financial Officer of Novo Holdings A/S, a position he has held since March 2022. In addition, Nigel is a member of the Board of Directors and Chair of the Audit Committee of NNIT A/S. From 2020 to 2022, Nigel was the Chief Financial Officer of Oman Infrastructure Investment Management. From 2014 to 2020, Nigel was Chief Financial Officer of the Sovereign Wealth Fund of Oman. Prior to this, Nigel held Director positions in EQT Fund Management Limited and EQT Partners UK, 2010-2014, and in Close Brothers including the role as Chief Operating Officer and Head of Fund Management (2007-2009). Nigel was a member of the Board of Directors of Outward Bound Oman from 2017-2022, and a member of the Board of Directors of Zain Group from 2017-2020. Nigel is Chair of the Board of Directors of Ejendomsselskabet Novo Holdings Komplementar ApS and Ejendomsselskabet Novo Holdings P/S, and Member of the Board of Directors of Novo Holdings US, Inc., as well as non-executive Chair of Tanjun 1 GP Limited in Guernsey (UK). Nigel is a UK national. He is admitted as a Fellow of the Association of Chartered Certified Accountants (ACCA) and holds a BA (Hons) Historical Studies from University of Sunderland and participated in the Global Board Education Programme with IMD in Lausanne.

Nine Cat Kejser is listed by Novo Holdings as Executive Assistant in Strategy and People. Further biography is not published on the reviewed profile.

Nis joined Novo Holdings A/S in 2016 and is Principal in the Planetary Health Investments team. Nis participates in deal sourcing and execution as well as in managing and developing the growing portfolio of investments. Prior to joining Novo Holdings, Nis was a Consultant with the Boston Consulting Group in their Copenhagen office. During his time with BCG, Nis worked primarily with Corporate Development and Strategy. Nis holds a MSc in Finance and Accounting and a BSc in International Business from Copenhagen Business School.

R. Bryan Jadot leads Hercules’ life-sciences investment group. He joined in 2005 following work at Silicon Valley Bank, BNP and the US Treasury. He studied economics and government at California State University, Sacramento.

Susan H. Saunders is currently Director of People Operations and Development in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2015. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Sr. Manager, HR Business Partner Sands Capital (2022 - 2023) Arlington, VA | Manager, HR Business Partner Sands Capital (2015 - 2021) Arlington, VA | Sr. HR Business Partner GridPoint, Inc. (2008 - 2015) Arlington, VA | Human Resources Generalist Family Advocacy Services (2007 - 2008) Newington, VA | Clinical Therapist For Children's Sake (2005 - 2007) Chantilly, VA | Case Manager. Education: Virginia Commonwealth University (2005) MSW | Clinical Concentration University of Colorado, Boulder (1999) BA | Psychology.

Avery A.K.L. Salisbury is currently Director of Compliance in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): ACA Global (2021 - 2022) Washington, D.C. | Senior Principal Consultant ExodusPoint Capital Management, LP ( 2020 – 2021) New York, NY | Deputy Chief Compliance Officer – Regulatory Compliance Gresham Investment Management, LLC (2015 - 2020) New York, NY | Managing Director & Chief Compliance Officer Eton Park Capital Management, LP (2013 – 2015) New York, NY | Senior Compliance Associate Anchorage Capital Group, LLC (2011 - 2013) New York, NY | Compliance Associate ACA Compliance Group (2010 - 2011) New York, NY |. Education: Trinity College (CT) (2007) BA | Political Science.

Adam Rosenbaum is currently Sr. Data Governance Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2025) Arlington, VA | Data Governance Analyst Biotechnology Innovation Organization (2019 - 2021) Washington, D.C. | Manager, Analytics Akamai (2018 - 2019) Reston, VA | Engagement Manager Council for Advancement and Support of Education (2006 - 2018) Washington, D.C. | Director, Information Systems and Architecture Council for Opportunity in Education (2004 - 2005) Washington, D.C. | Assistant Director, Technology Education Democracy Data & Communications (2000 - 2004) Alexandria, VA | Database Administrator & Operations Specialist Montgomery County Public Schools (1995 -. Education: University Maryland Global Campus (2001) MS | Information Resource Management University of Colorado (1990) BA | Political Science.

Patricia D. Rodriguez is currently Reconciliation Administration Supervisor in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 1999. Published career chronology (historical appointments): Sands Capital (2004 - 2008)Arlington, VA | Sr. Reconciliation Administrator Sands Capital (2003 - 2004)Arlington, VA | Trade Settlement Specialist Sands Capital (1999 - 2003)Arlington, VA | Account Administrator.

Timothy Richter is currently Director, Fund and Investment Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2025) Arlington, VA | Sr. Manager, Fund and Investment Operations Barings, LLC (2021 - 2022) Charlotte, NC | Director – Head of US and UK High Yield Portfolio Services Barings, LLC (2018 - 2020) Charlotte, NC | Manager – Global Client and Portfolio Services Barings, LLC (2015 - 2018) Charlotte, NC | Associate Director – Global Client and Portfolio Services Babson Capital Management (2013 - 2015) Charlotte, NC | Analyst – Global Client and Portfolio Services BMO Financial Group (2010 -. Education: University of Wisconsin (2010) BA | Economics.

Elma Rahman is currently Sr. Technology Coordinator in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2025) Arlington, VA | Technology Coordinator Gensler (2017 - 2021) Washington, D.C. | Studio Coordinator Gensler (2011 - 2017) Washington, D.C. | Executive Assistant Infectious Diseases Society of America (2007 - 2010) Arlington, VA | Administrative Coordinator Legg Mason Wood Walker, Inc. (2001 - 2006) Alexandria, VA | Client Services Representative. Education: George Mason University (2001) BA | English.

Eric C. Perlish is currently Managing Director, Head of Trading and Risk Analytics in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2011. Published career chronology (historical appointments): Sands Capital (2020 - 2024) Arlington, VA | Global Head of Trading Sands Capital (2015 - 2019) Arlington, VA | Head of Global Trading Sands Capital (2011 - 2014) Arlington, VA | Sr. Trader Ironbound Capital (2004 - 2010) Princeton, NJ | Head Trader Cisco Systems (2004) Malvern, PA | Project Analyst Merrill Lynch Investment Managers (1998 - 2003) Plainsboro, NJ | Assistant Vice President. Education: Rider University (1997) BBA | Actuarial Science and Finance.

Vedavyas Munugoor is currently Investment Systems Support Engineer in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): RainFocus (2023 – 2025) Arlington, VA | Data Integration Engineer Fidelity Investments (2020 – 2023) Boston, MA | Investment Systems Engineer. Education: Wentworth Institute of Technology (2021) BS | Computer Science.

Nicolaj joined Novo Holdings A/S in March 2024 as a Data Engineer. He contributes to the enhancement of the data platform and elevating advanced analytics capabilities. Prior to being at Novo Holdings A/S, Nicolaj worked at Ørsted as a part of the Market Data Team in the Department of Financial Risk Management and Market Analytics, focusing on data enhancement and analytics for FX and commodity markets. Nicolaj holds a BSc in Mathematics and Technology and an honors MSc in Mathematical Modeling and Computation from the Technical University of Denmark, complemented by a semester at Cornell University.

Nicole Jepsen joined Novo Holdings A/S as Personal Assistant in Capital Investments in September 2020. Prior to joining Novo Holdings A/S, Nicole was employed as Executive Assistant and Head of HR at the commercial property advisor Nordicals København A/S- Savills for 7 years. Other previous employments include positions as Operations Manager at KfW IPEX-Bank in London and EA at Verint Systems in Germany. Nicole holds a BA degree in Modern Languages and Cultural Mediation from the University of Southern Denmark.

Nick joined Novo Holdings in May 2026 as a Senior Investment Operations Specialist in Finance & Operations. Prior to joining Novo Holdings, Nick worked 11 years in the financial sector. First five years in Jyske Bank as an Investment Operations Specialist, then one year at Investering & Tryghed as an Investment Controller and latest five years at Aleta as an Investment Operations Manager. Nick holds a Graduate Diploma in Business Administration (Finance).

Nav joined Novo Holdings Asia in August 2021. He focusses on deal sourcing and execution as well as in managing and developing the growing portfolio of investments, focusing primarily on the markets in China, India, and Southeast Asia. Prior to joining Novo Holdings Asia, Nav was a Director in Quadria Capital, a mid-market private equity firm focusing on healthcare investments in India and South East Asia. Before joining Quadria Capital, Nav was the Managing Director at Fosun, where he worked on both private and public healthcare investment opportunities across the Asia-Pacific region. Nav started his investment career with Merrill Lynch in Hong Kong and moved to UBS Global Asset Management in Singapore before joining Fosun. Nav holds an MBA from Indian Institute of Management (IIM), Ahmedabad, in India and Bachelor of Technology from Indian institute of Technology (IIT), Kharagpur in India.

Jasmine Saadati oversees corporate development, institutional fundraising and limited-partner relationships for the Hercules private-credit platform and Hercules Adviser. She previously spent more than ten years at SVB Capital across credit, product and investor relations.

Gery Lefebvre is an investment manager in the Q4 2024 WE Life Sciences roster since 2014, with management and finance experience including treasury and working-capital responsibilities at GSK Biologicals. Holds HEC-ULiège business-administration and taxation master’s degrees. The dated public roster does not by itself establish a new employment start day or uninterrupted tenure through October 2026.

Board Director at Cancer Treatment Centers of America Formerly President, CEO and Board Director for PDI, and CMO at Novartis US

Naveed joined Novo Holdings A/S in 2019 and works from London and Copenhagen as a Senior Partner in Venture Investments. He brings more than 25 years of experience in life science investments and investment banking.  Between 2013 and 2018, he was Partner at Andera Partners, a Paris based venture capital and growth equity firm with over 2 billion euros under management, focusing on life science investing.  He has also worked for Nomura Phase4 Ventures, Nomura International, EFG Corporate Finance, KPMG and as a medical doctor in the UK’s National Health Service.  During his career he has served on multiple European and US boards.  At Novo Holdings he has served on the Boards of Amolyt (acquired by AstraZeneca), Reviral (acquired by Pfizer), Vectivbio (IPO on NASDAQ and acquired by Ironwood), Alentis Therapeutics,  Asceneuron, F2G and Windward Bio. He also served as Board Observer at Numab (sale of Yellow Jersey Therapeutics to J&J).   Naveed obtained his medical degree from Guy’s and St Thomas’s Hospital Medical School (now King’s College London). Later, he also qualified as a chartered accountant from the Institute of Chartered Accountants England & Wales.

Nana joined Novo Holdings in November 2022 as Senior P&O Partner in the People & Organisation team. She supports and collaborates closely with Leaders and teams on topics linked to the people agenda to ensure we uphold an inclusive and performance-driven workplace, and supports the development journeys of our people professionally and personally. Prior to joining Novo Holdings, Nana worked at McKinsey & Company in Copenhagen for 15 years in the People Development team, overseeing people matters and was responsible for the development and staffing of consultants, as well as being advisor and sparring partner for the Leadership team. Nana holds a BSc in Business Administration and Psychology and an MSc in Strategy, Organisation and Leadership from Copenhagen Business School.

Mark J. Muldoon is currently Sr. Trader in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2012. Published career chronology (historical appointments): Sands Capital (2023) Arlington, VA | Trader Sands Capital (2021 - 2022) Arlington, VA | Sr. Trading Analyst Sands Capital (2015 - 2020) Arlington, VA | Trading Analyst Sands Capital (2012 - 2015) Arlington, VA | Sr. Global Administrator Bank of New York Mellon (2010 - 2012) New York, NY | Product Derivatives Analyst SS&C Technologies (2006 - 2010) Windsor, CT | Derivatives Analyst. Education: Central Connecticut State University (2006) BS | Finance.

Hannah Montfort is currently Office and Events Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2025) Arlington, VA | Office and Events Coordinator Cosmos Club (2019-2022) Washington, D.C. | Member Events Manager. Education: University of South Carolina (2019) BS | College of Hospitality, Tourism and Sport Management.

Silvio Minuto is currently Trade Settlement Supervisor in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2013. Published career chronology (historical appointments): Sands Capital (2013 - 2017) Arlington, VA | Sr. Reconciliation Administrator and Trade Support Specialist First Republic Investment Management (2008 - 2012) New York, NY | Operations/Trading Associate Byram Capital Management LLC (2005 - 2008) Greenwich, CT | Portfolio Administrator Paratus Partners LLC (2004) Stamford, CT | Trading/Research Associate Globe Op Financial Services (2002 - 2004) Harrison, NY | Documentation Analyst JSK Associates Inc. (1998 - 2002) White Plains, NY | Administrative Assistant/Compliance Trainee. Education: Iona College (2001) BBA | Business Management.

Emily H. Miller is currently Sr. Manager, Talent Acquisition in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2023 - 2024) Arlington, VA | Manager, Talent Acquisition Sands Capital (2021 - 2022) Arlington, VA | Sr. Talent Acquisition Specialist, HR Business Partner Sands Capital (2020) Arlington, VA | HR Business Partner, Talent Acquisition Specialist Sands Capital (2016 – 2019) Arlington, VA | HR Generalist Wafra Investment Advisory Group, Inc. (2014 - 2016) New York, NY | Human Resources Coordinator BDO USA, LLP (2014) New York, NY | Human Resources Assistant. Education: Georgetown University (2019) MPS | HR Management, Strategic Human Capital Development Marist College (2013) BA | Psychology.

Jacob S. Miller is currently Head of Accounting and Finance in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2023 - 2024) Arlington, VA | Director of Finance Sands Capital (2019 - 2022) Arlington, VA | Manager, Finance Sands Capital (2016 - 2018) Arlington, VA | Sr. Financial Analyst Sands Capital (2014 - 2016) Arlington, VA | Financial Analyst General Services Administration (2011 - 2014) Washington, D.C. | Financial Analyst. Education: University of North Carolina at Chapel Hill (2020) MAC | Accountancy Georgetown University (2018) MBA | McDonough School of Business Bucknell University (2011) BA | Economics and Political Science.

Dana M. McNamara is currently Chief Administrative Officer Executive Managing Director in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2000. Published career chronology (historical appointments): Sands Capital (2014) Arlington, VA | Managing Director, Co-Chief Administrative Officer Sands Capital (2000 - 2014) Arlington, VA | Director, Client Services and Operations Cardinal Wealth Services, Inc. (1999 - 2000) Fairfax, VA | Registered Sales Assistant Crestar Bank, NA (1997 - 1999) Vienna, VA | Registered Sales Assistant Crestar Bank, NA (1992 - 1997) Vienna, VA | Banking Branch Manager. Education: University of Virginia (2014) MBA | Darden School of Business James Madison University (1992) BBA | Finance.

Nick Martin is currently AI Solutions Team in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): Sands Capital (2023 - 2025) Arlington, VA | Director, AI Solutions Searchable AI (2019 - 2023) San Francisco, CA | Co-founder & CTO In-Q-Tel (2015 - 2019) Arlington, VA | Sr. MTS H2O AI (2015) Mountain View, CA | Head of Customer Data Science McKesson (2012 - 2015) Jacksonville, FL & San Francisco, CA | Sr. Big Data Architect Citi (2011 - 2012) Jacksonville, FL | AVP BAE Systems (2006 - 2010) Jacksonville, FL | Sr. Information Architect. Education: University of North Florida (2003) BA | History.

David E. Markle is currently Director, Software Engineering in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2017. Published career chronology (historical appointments): Sands Capital (2017 – 2020) Arlington, VA | Software Development Manager Potomac Solutions Group (2007 - 2017) Arlington, VA | Consultant Markle Consulting, LLC (2003 - 2007) Arlington, VA | Consultant Tririum Card Services, LLC (1999 - 2002) Uniondale, NY | SVP, Development PriceInteractive (1998 - 1999) Reston, VA | Senior Developer. Education: Virginia Tech (1998) BS | Computer Engineering.

Naomi Cheng joined Hercules as corporate controller in April2025. Her finance experience includes Kleiner Perkins, Norwest, Salesforce, Netflix and Deloitte. She studied business at Berkeley and is a CPA.

Morten joined Novo Holdings in March 2005 as an Investment Director in Capital Investments. Morten holds a MSc in Finance and Accounting from the Aarhus School of Business, Denmark and an EMBA from IMD, Switzerland. Prior to joining Novo Holdings Morten was employed at Novo Nordisk and Nordea Markets.

Nana joined Novo Holdings A/S in January 2025 as a Digital Change Manager. She is supporting the adoption and implementation of Novo Holding's digital transformation and strategy.  Prior to joining Novo Holdings A/S, Nana was at Microsoft A/S as a Cloud solution architect, There her main focus was to drive digital transformation and overall digital strategies between Microsoft and customers.  Nana holds a MSc.Eng in Operations and Process optimization from Aalborg University and a BSc in Industrial Engineering from Technical University of Denmark.

Mikkel joined Novo Holdings in August 2022 as an Associate in Capital Investments. He focuses on investments in real assets and participates in deal sourcing and execution, as well as in managing the existing portfolio. During his studies, Mikkel worked as a Junior Analyst at Novo Holdings and at ABG Sundal Collier. Mikkel holds a MSc in Advanced Economics and Finance and a BSc in International Business, both from Copenhagen Business School

Michelle joined Novo Holdings Asia in 2021 as Office Manager. She is in charge of office and facility management and offers administrative support to our Singapore office. Prior to joining Novo Holdings, Michelle was Executive Assistant at Monsanto Singapore and most recently Office Manager at King Street Singapore. Michelle holds a Bachelor of Arts in Business Administration and Management from the University of Derby.

Caroline Thielen is an investment manager in the published Q4 2024 WE Life Sciences roster, with over 20years of research coordination and a former COO role at Bridge2Health. Holds biology and immunology degrees from the University of Liège and completed CDC postdoctoral training. The dated public roster does not by itself establish a new employment start day or uninterrupted tenure through October 2026.

Marielle Papy is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Charlie Vandis became chief credit officer in 2022 after joining Hercules in 2017 in East Coast credit. Earlier, he spent sixteen years at GE in underwriting and credit roles. His education includes Tufts and an MBA at USC.

Michael joined Novo Holdings in 2025 as an Associate in the Principal Investments group. He participates in deal sourcing and execution as well as in managing and developing the growing portfolio of investments.Prior to Novo Holdings, Michael was an Investment Banking Analyst in the healthcare group at Citi and an intern with Firelight Capital Partners.  Michael holds a BBA, cum laude, in Finance from the University of Notre Dame.

Michael Johnson joined Principal Investments in June 2022 as an Associate in our Boston office. Michael has been involved in healthcare investing and advisory since 2019. Prior to Novo Holdings Equity US, he served as an investment banking associate at William Blair. Additionally, he was an analyst in the healthcare investment banking group at JMP Securities. He began his career in audit and assurance at Deloitte. Michael holds a BA in Finance and Economics and a BS in Accounting from the University of Kentucky.

Michael joined Venture Investments in November 2020. From 2006-2020, Michael was employed at Genmab in various positions with increasing responsibility; starting in Project Management taking daratumumab / DARZALEX® into the clinic. Between 2010-2018 he led Clinical Development and was part of the senior leadership team that repositioned and rebuilt the company into a global cancer and antibody powerhouse. From 2018 he led R&D Operations preparing the company for filing of its first own product. Prior to Genmab, Michael worked as Associate at BankInvest Biomedical Venture and as Licensing Associate in Scientific Licensing at Novo Nordisk A/S, after having spent 7 years as Research Scientist at Novo Nordisk A/S covering areas such as endocrinology, metabolic disease, cancer and inflammation. Before joining the industry, Michael worked for 6 years at the Research Centre for Developmental Medicine & Biology at the University of Auckland, New Zealand, investigating causes and possible treatment modalities of intra-uterine growth restriction. Michael earned a Masters (Dipl. Ing. agr.) in Agricultural Science from the University of Stuttgart-Hohenheim, Germany and a Ph.D. in Agricultural Science – summa cum laude – from the University of Göttingen, Germany.

Mia Bøttzauw-Jørgensen is listed by Novo Holdings as Senior Manager in Finance & Operations. Further biography is not published on the reviewed profile.

Anne-Sophie Tandel is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Ricardo J. Lopez is currently Sr. Manager, Investment Systems in Sands Capital’s published firmwide directory. The biography records joining or rejoining: Re-joined in 2022. Published career chronology (historical appointments): Capital One (2020 - 2022) McLean, VA | Head of Reporting & Oversight Sands Capital (2012 - 2020) Arlington, VA | Supervisor, Investment Operations Geller Family Office Services, LLC (2007 - 2012) New York, NY | Manager, FOS Investment Reporting Operations Fortigent, LLC (2005 - 2007) Rockville, MD | Sr. Portfolio Accounting Analyst. Education: University of Maryland (2004) BA | Economics.

Jeff Lewis is currently Sr. Manager, Software and Data Engineering in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): SchoolBee (2013 ‐ Present) New York, NY | Principal StreetConnect (2011 - Present) New York, NY | Principal Ipreo (2007 - 2010) New York, NY | Managing Director NSight Enterprise Software (2003 - 2007) New York, NY | Co-Founder & CTO Arcadyn Solutions (2001 - 2004) New York, NY | Managing Partner Triene (2000 - 2001) New York, NY | Software Developer FactSet Research Systems (1996 - 2000) Greenwich, CT | Application Development Manager. Education: The University of Iowa Tippie College of Business (1996) BA | Finance & MIS.

Barry Leese is currently Analyst, Investment Compliance in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2023) Arlington, VA | Compliance Associate Booz Allen Hamilton (2019 - 2021) McLean, VA | Regulatory Compliance Analyst William Price Financial Planning (2018 - 2019) Barnesville, MD | Intern. Education: University of Denver (2019) BA | Economics.

Gina Ledwidge is currently Legal Counsel in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2025) Arlington, VA | Associate Legal Counsel The Baupost Group, L.L.C. (2019 - 2022) Boston, MA | Associate Counsel The Baupost Group, L.L.C. (2017 - 2019) Boston, MA | Senior Paralegal The Baupost Group, L.L.C. (2013 - 2016) Boston, MA | Legal Assistant The Baupost Group, L.L.C. (2011 - 2013) Boston, MA | Administrative Support. Education: Suffolk University Law School (2018) Juris Doctor The University of Rhode Island (2010) BA | Political Science BA | French Language and Literature.

Kellie M. Lavey is currently Office and Events Administrator in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2015. Published career chronology (historical appointments): Sands Capital (2015 - 2024) Arlington, VA | Receptionist and Office Coordinator GlobalLogic, Inc. (2014 - 2015) McLean, VA | Office Manager/Administrative Support Transportation Security Administration (2012 - 2014) Sterling, VA | Transportation Security Officer United Airlines (1990 - 2005) Dulles, VA | Flight Attendant.

Kristen N. Ketchum is currently Operations Manager, Stewardship and PACT in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2013. Published career chronology (historical appointments): Sands Capital (2020 - 2025) Arlington, VA | Sr. Executive Assistant Sands Capital (2013 - 2019) Arlington, VA | Executive Assistant Deltek, Inc. (2007 - 2012) Hernedon, VA | Executive Assistant Vornado/Charles E. Smith (2004 - 2007) Washington, D.C. | Administration Operations Manager JP Morgan Chase Bank (2003 - 2004) Washington, D.C. | Administrative Assistant CB Richard Ellis (1996 - 2002) Washington, D.C. | Office Manager. Education: University of Maryland (1996) BA | Graphic Design.

Drew Keller is currently Manager, Compliance Operations and Regulatory Filings in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): FORT LP (2008 - 2023) Chevy Chase, MD | Chief Compliance Officer & Deputy Chief Operating Officer. Education: University of Virginia (2006) MA | Chemistry University of Richmond (2005) BS | Chemistry.

Jeremiah J. Kayal is currently Head of Global Trading in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2012. Published career chronology (historical appointments): Sands Capital (2019 - 2024) Arlington, VA | Sr. Trader Sands Capital (2014 - 2018) Arlington, VA | Trader Sands Capital (2012 - 2014) Arlington, VA | Jr. Trader. Education: Georgetown University (2012) BSBA | Finance, McDonough School of Business.

Clarisse Ramakers is listed by Wallonie Entreprendre in its current public governance directory as independent board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Kate Kinlin joined Hercules in April2022 to lead human resources. Her previous HR work includes Capital Crossing and F-Squared. She studied leadership and economics at the University of Delaware.

Pierre Parlongue is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Merete joined Novo Holdings A/S in 2021 as an Accountant in Finance & Operations and handles various accounting tasks including supplier and debtor processes, expense management, Bank- and Intercompany reconciliations, month end closing a.o. Prior to being at Novo Holdings A/S, Merete held positions as Accounting Assistant in Peter Bodum A/S, Tivoli A/S, Triumph International A/S, Multi-Wing International A/S and Coloplast A/S. Merete holds a Bachelor of Commerce.

2020 – CEO, PDGx 2018 – 2020: Various roles with PDGx, including Chief Commercial Officer and Vice President, Marketing 2016 – 2018: Senior Director, Sales, Roche 2012 – 2015: Group Marketing Manager, Roche 2008 – 2012: Various positions at Ventana Medical Systems, including Senior International Product Manager

Michael Hara leads investor relations and corporate communications at Hercules. His earlier career includes Cortina Systems and NVIDIA, where he worked in marketing and subsequently led investor relations during 2000–2011. His professional background spans semiconductor and software companies.

Matthieu Possoz is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Maurits Brandt joined Novo Holdings in 2022 as a Senior Associate in Seed Investments. Prior to Novo Holdings Maurits had a Business Development role in ProQR Therapeutics, a biotech company developing oligonucleotide based therapeutics. Here he was responsible for in- and outlicensing of various assets and technologies and aided in the internal business development. Prior to this, he was Senior Analyst at Aescap, a public equity investment fund with a focus on innovative therapeutics. Maurits holds a BSc in Chemistry and an MSc in Molecular Biology, both from Leiden University.

Sabrina Iqbal is currently Sr. Manager, Enterprise Project Portfolio in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2010. Published career chronology (historical appointments): Sands Capital (2023 - 2024) Arlington, VA | Manager, Enterprise Project Portfolio Sands Capital (2020 - 2022) Arlington, VA | Project Manager Sands Capital (2016 - 2019) Arlington, VA | Project Management Analyst Sands Capital (2015 - 2016) Arlington, VA | Client Relations Project Specialist Sands Capital (2010 - 2015) Arlington, VA | Client Relations Associate AXA Advisors (2010) Fairfax, VA | Producer Associate Merrill Lynch (2007 - 2009) Pennington, NJ | Marketing Analyst. Education: Johns Hopkins University (2022) MBA | Carey Business School Bethany College (2007) BA | Economics.

HanNa Hur is currently Compliance Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): ACA Group (2021 - 2023) VA Home Office | Consultant Hardin Compliance Consulting (2018 - 2021) VA Home Office | Senior Compliance Associate Hyundai Power Transformers USA, Inc (2015 - 2016) Montgomery, AL | Legal Specialist United States District Court Northern District of Alabama (2014 - 2015) Tuscaloosa, AL | Intern to Judge L. Scott Coogler Office of the President of the Republic of Korea (2012) Seoul, South Korea | Intern to the Legal Secretary of the President. Education: The University of Alabama School of Law (2014) LLM Hankuk University of Foreign Studies (2013) LLB | Law.

Karen E. Hsu is currently Manager, Risk Analytics in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Sr. Portfolio Risk Analyst Sands Capital (2020 - 2021) Arlington, VA | Portfolio Risk Analyst Sands Capital (2018 - 2020) Arlington, VA | Portfolio Analyst Sands Capital (2016 - 2017) Arlington, VA | Associate Portfolio Data Analyst T. Rowe Price (2013 - 2015) Baltimore, MD | Business Analyst Ashmore Equity Investment Management (2012 - 2013) Arlington, VA | Research Associate. Education: Duke University (2020) MBA | Fuqua School of Business University of Maryland (2011) BA | Economics.

Michael Hetzner is currently Trader in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Allspring Global Investments (2021 - 2025) Los Angeles, CA | Systematic Trader Wells Fargo Asset Management (2016 - 2021) Los Angeles, CA | Securities Trader Analytic Investors (2015 - 2016) Los Angeles, CA | Trader Matthews International Capital Management (2009 - 2015) San Francisco, CA | Trader Neonet Securities (2007 - 2009) Jersey City, NJ | Asia Pacific, Trader. Education: Villanova University (2006) MS | Finance Northern Michigan University (2002) BS | Finance.

Kyle R. Hennies is currently Planning and Analytics Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2018. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Sr. Planning and Analytics Associate Sands Capital (2018 - 2021) Arlington, VA | Planning and Analytics Associate. Education: University of Louisville (2018) BSBA | Finance.

Christopher D. Head is currently Sr. Full Stack Developer, Data Engineering in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Sands Capital (2020 - 2024) Arlington, VA | Full Stack Developer, Data Focus S&P Global Market Intelligence (2019 - 2020) Richmond, VA | Business Systems Analyst II Owens and Minor (2018 - 2019) Richmond, VA | Financial Analyst (Rebates) Harris Williams (2016 - 2018) Richmond, VA | Accounting Analyst. Education: University of Virginia (2019) MS | Business Analytics, Darden School & McIntire School of Commerce Virginia Commonwealth University (2016) BS | Finance.

Nikki Hartzoulakis is currently Assistant to the President, Sr. Research Resource Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2015. Published career chronology (historical appointments): Sands Capital (2020 - 2024) Arlington, VA | Assistant to the President, Research Resource Specialist Sands Capital (2015 - 2019) Arlington, VA | Executive Assistant Lincoln Center for the Performing Arts (2013 - 2015) New York, NY | Executive Assistant to the Executive Director, LCDP SunGard (2012 - 2013) New York, NY | Recruiting Coordinator SunGard (2006 - 2012) New York, NY | Administrative Assistant. Education: Hunter College (2018) BA | Sociology Borough of Manhattan Community College (2005) AS | Business Management.

Yolande J. Hanlan is currently Sr. Director, Sr. Counsel in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2018. Published career chronology (historical appointments): Sands Capital (2022 – 2024) Arlington, VA | Director, Sr. Counsel Sands Capital (2018 – 2021) Arlington, VA | Legal Counsel Georgetown University (2015 - 2019) Washington, DC | Adjunct Professor, School of Foreign Service White & Case LLC (2012 - 2018) Washington, DC | Associate The Monitor Group (2004 - 2008) Toronto, ON and Paris, France | Consultant. Education: Georgetown University (2012) Juris Doctor MS | School of Foreign Service Queen's University (2004) BA | Sociology BCom | Smith School of Business.

Renaud Moens is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate. Renaud Moens is published in Sambrinvest’s current governance roster. The official Belgian enterprise register corroborates this legal governance appointment, separate from investment-team employment and personal investment attribution.

About Mauricio Graber Mexican citizen Board positions Mauricio serves as a member of the Board of Directors of Bacthera AG, Jungbunzlauer Suisse AG and Barry Callebaut, all in Switzerland. Career 2018 – 2024      CEO, Chr. Hansen, Denmark 2006 – 2018     President, Flavours Division, Givaudan S.A 2000- 2006       VP, Latin America and member of the Flavour Division management team, Givaudan S.A. 1997 – 2000      Managing Director, Mexico, Central America and the Caribbean, Givaudan S.A. 1995 – 1997       Managing Director, Latin America, Tastemaker. 1991 – 1994        Regional Head, North Latin America, The NutraSweet Company 1989 – 1991        Business Development Manager, The NutraSweet Company Education Mauricio holds a Master of Business Administration from Kellogg Graduate School of Management, Northwestern University, US. He also has a Bachelor of Science in Electronic Engineering, Universidad Autonoma Metropolitana, Mexico.

Mathias joined Novo Holdings in October 2024 as a Principal in Capital Investments. He is responsible for direct investment opportunities within infrastructure and green transition. Prior to joining Novo Holdings, Mathias gained experience from working with infrastructure at PensionDanmark, and have previously held several roles at Nordea. Mathias holds a MSc in Finance and Investments from Copenhagen Business School.

Christine Defraigne is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Prior to joining Novo Holdings US Inc., Matthew was Director and Tax Counsel at Organon & Co, where he focused on business development, transaction support, and tax planning. Before that, he was with KPMG LLP, advising clients on crossborder mergers & acquisitions, including due diligence, transaction structuring, tax and financial modeling, and purchase agreement review, as well as broader tax consulting on a range of matters. Matthew holds an LL.M. in Taxation from New York University School of Law, a J.D. from Northeastern University School of Law, and a B.S. in Accounting from Northeastern University.

Mathias joined Novo Holdings A/S in October 2022 as an Associate in Principal Investments. He participates in deal sourcing and execution, as well as in managing the existing portfolio. Prior to joining Novo Holdings, Mathias worked in Investment Banking at Carnegie, focusing on buy-side and sell-side M&A advisory as well as IPO advisory. Mathias holds a BSc in Economics and Business Administration and MSc in Applied Economics and Finance from Copenhagen Business School.

Christian Follmann became Hercules’ chief operating officer in February2022. Beginning with an internship in 2006, his work progressed through finance, strategy and operations. He studied international business through Northeastern and Reutlingen.

Michele Daniele is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Ian Gregg is currently Technical Business Analyst, Enterprise Technology and Data in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): EastBanc Technologies, Consultant at Sands Capital (2021 - 2024) Washington, D.C. | Project Coordinator – Scrum Master Bank of America (2017 - 2021) Charlotte, NC | Vice President, Technical Product Owner Lowe’s Companies (2016 - 2017) Mooresville, NC | Digital IT Business Analyst. Education: Virginia Tech (2025) MS | Information Technology Virginia Tech (2016) BS | Business Information Technology.

Jonathan P. Goodman is currently General Counsel in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2012. Published career chronology (historical appointments): Sands Capital (2012 - 2013) Arlington, VA | Legal Counsel Gibson, Dunn and Crutcher LLP (2007 - 2012) Washington, D.C. | Attorney Cravath, Swaine and Moore LLP (2003 - 2006) New York, NY and London, UK | Attorney. Education: Georgetown Law (2003) Juris Doctor University of Wisconsin-Madison (1997) BA | Political Science and Japanese.

Sergio Gomez is currently Accounting Manager in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): KPMG (2016 - 2018) Philadelphia, PA | Audit Senior Centri Business Consulting (2018 - 2021) Philadelphia, PA | Senior Accountant Archwell Holdings (2021 - 2023) Philadelphia, PA | Accounting Manager. Education: The Pennsylvania State University (2016) MS | Accounting The Pennsylvania State University (2015) BS | Accounting.

Doug Gibson is currently Investment Operations Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): T. Rowe Price (2023 - 2025) Baltimore, MD | Business Analyst Bloomberg (2022 - 2023) Princeton, NJ | Financial Data Analyst Newrez (2021 - 2022) Columbia, MD | Mortgage Consultant. Education: University of Maryland, College Park BS | Finance (2020).

Pamela L. Gendell is currently Manager, Marketing, Advertising, and Communication Compliance in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2015. Published career chronology (historical appointments): Sands Capital (2015 - 2021) Arlington, VA | Sr. Compliance Analyst T. Rowe Price Associates (2004 - 2015) Baltimore, MD | Compliance Consultant Deutsche Asset Management (2000 - 2004) Baltimore, MD | Compliance Officer, Assistant Vice President T. Rowe Price (1994 - 1999) Washington, DC | Branch Manager. Education: University of Maryland (1991) BA | Economics.

Alexandra Fulk is currently Chief Compliance Officer, Sr. Counsel in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2022 - 2023) Chief Compliance Officer (SCV), Sr. Legal Counsel Sands Capital (2021 - 2022) Sr. Legal Counsel, Director of Compliance (SCV) SoftBank Investment Advisers (2018 - 2021) San Carlos, CA | Director Cordium (2016 - 2018) San Francisco, CA | Vice President Rock Springs Capital Management (2015 - 2016) Baltimore, MD | Deputy General Counsel, Deputy Chief Compliance Officer Bank of America Merrill Lynch (2013 - 2014) New York, NY | Vice President Cavalry Asset Management (2012 – 2013) San Francisco, CA. Education: Cornell Law School (2009) Juris Doctor University of Maryland (2005) BS | International Business.

Emily Freije is currently Executive Business Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2010. Published career chronology (historical appointments): Sands Capital (2010 - 2024) Arlington, VA | Assistant to the CEO Ganz, USA (2008 - 2009) Atlanta, GA | Executive Assistant to the National Sales Director The ALC Group (2005 - 2008) Atlanta, GA | Legal Recruiter. Education: James Madison University BS | Social Sciences.

Semone N. Fraser is currently Sr. Trade Settlement Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2008. Published career chronology (historical appointments): Sands Capital (2013 - 2015) Arlington, VA | Global Administrator Sands Capital (2008 - 2012) Arlington, VA | Global Reconciliation Administrator Hughes Capital Management (2007 - 2008) Alexandria, VA | Portfolio Administrator Barclays Capital (1997 - 2006) New York, NY | Fixed Income Sales Assistant. Education: University of Phoenix (2014) BS | Business Administration, Finance University of Phoenix (2011) Associates | Business Management, Finance.

Mathias joined Novo Holdings A/S in April 2022 as an Associate in Principal Investments. He participates in deal sourcing and execution as well as in managing and developing the growing portfolio of investments. Prior to joining Novo Holdings A/S, Mathias worked as an Analyst at Nordea Corporate Finance in their Copenhagen office. During this time, Mathias worked with both private and public transactions across a broad range of sectors. Mathias holds a BSc in Business Administration & Economics and an MSc in Finance and Accounting from Copenhagen Business School.

Philippe Crevits is listed by Wallonie Entreprendre in its current public governance directory as board member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Mary joined Novo Holdings in 2023 as an Executive Assistant to the US Principal Investments team based in Boston. Prior to joining Novo Holdings, she worked as an Event Coordinator specializing in private dining. Mary received a Bachelor of Science degree from the University of Massachusetts Amherst in Hospitality and Tourism Management.

Mark joined Novo Holdings in January 2022 as a Data Warehouse Specialist in the Valuation & Performance team. Prior to joining Novo Holdings, Mark gained experience from Nykredit in the Group Finance & Investments department and as a Business Intelligence Developer at Trafikselskabet Movia. Mark is responsible for the development and architecture of Novo Holdings’ cloud-native Data Warehouse and management of related data integrations. Mark also assists the business intelligence development and operations. Mark holds a MSc in Economics and Finance from the University of Copenhagen.

Markus joined Novo Holdings in June 2024 as a valuation specialist in Finance & Operations. He participates in valuation and performance measurement activities. This includes quarterly fair market value assessments of the portfolio companies as well as valuation and modelling support to the investment teams. Prior to joining Novo Holdings, Markus held a position in the Corporate Finance team at KPMG, where he worked on different projects especially within valuation in green energy and obtained comprehensive knowledge about valuation and financial modelling. Markus holds a MSc in Finance & Investments from Copenhagen Business School.

Kiersten Zaza Botelho leads legal and compliance at Hercules, which she joined in 2022. Her previous work spans Bain Capital Credit, BlackRock and Skadden. She studied international relations and law at Boston University.

Jean Hilgers is listed by Wallonie Entreprendre in its current public governance directory as board chair. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Markus joined Novo Holdings in April 2024 as Partner in Capital Investments. He holds a degree in Finance from University of Applied Sciences and Arts Northwestern Switzerland (Basel) and an EMBA from INSEAD, Fontainebleau/Singapore. He is a CFA Charterholder. Prior to joining Novo Holdings Markus was employed at Suva in Switzerland. Before that he worked as a co-founder of an investment advisory firm, as well as for Rothschild Bank and VZ VermögensZentrum.

Marie Schroeder joined Seed Investments in 2023. Marie holds several board positions and is focused on early-stage investments, particularly in the cardiometabolic space. She has 10+ years of experience as a scientist in cardiometabolic diseases, in both the pharmaceutical industry and academia. Most recently, Marie was a principal scientist in cardiovascular diseases at Novo Nordisk. She contributed to strategic development of the therapeutic area and managed multiple projects within the internal pre-clinical pipeline, from ideation stage to approaching development candidate nomination. Further, Marie was a key driver of multiple external partnerships with academia and industry. Marie has a DPhil from the University of Oxford (Lincoln College), a bachelor’s degree in biomedical and electrical engineering from Duke University, and she is a Fulbright scholar. Her academic research focused on advanced MRI techniques for cardiometabolic imaging; her work was funded via fellowships from Oxford, the Wellcome Trust and the NIH.

Maria joined Novo Holdings in November 2023 as a Principal in Capital Investments. She is responsible for analyzing fund and co-investment opportunities within infrastructure and green transition. Prior to joining Novo Holdings, Maria gained experience from a specialist fund-of-funds manager, Danske Bank, A.P. Moller-Maersk and Ørsted. Maria holds a MSc in Economics from the University of Copenhagen.

Mark Lee joined Novo Holdings in 2025 as a Vice President in the Planetary Health Investment team and is based in the San Francisco office. Prior to Novo Holdings, Mark worked in corporate development at Sidewalk Labs (Alphabet’s urban innovation arm), incubating a mass timber construction platform delivering sustainable, pre-fabricated buildings. Before Sidewalk, Mark was an Associate at FFL Partners, a middle-market private equity firm, focused on industrial technology buyouts. Mark started his career in technology investment banking at Lazard Freres and RBC Capital Markets. Mark holds an MBA from Stanford University, and a BA in Philosophy (First Class Honours) and BComm in Finance from the University of Calgary.

Anne Vereecke is listed by Wallonie Entreprendre in its current public governance directory as extended executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Shou-Wei Fan is currently Head of Public Markets Investment Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2016 - 2025) Arlington, VA | Director, Investment Operations Brown Brother's Harriman (2008 - 2016) New York, NY | Vice President, Investment Management Services Deutsche Asset Management (2005 - 2008) New York, NY | Assistant Vice President, Corporate Action Manager State Street Ireland (2003 - 2004) Kilkenny, Ireland | Integration Coordinator State Street Corporation (2002 - 2003) Boston, MA | Account Manager State Street Luxembourg (2000 - 2002) Luxembourg City, Luxembourg | Fund Admin Account Manager State Street Corporation (1997 - 2000) Boston,. Education: Boston University (1997) BS | Business Administration.

Patrick Everett is currently Sr. Manager, Investment Compliance in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2023 - 2024) Arlington, VA | Manager, Investment Compliance Sands Capital (2022) Arlington, VA | Senior Analyst, Investment Compliance Sands Capital (2021 - 2022) Arlington, VA | Sr. Compliance Analyst Legg Mason, Inc. (2006-2020) Baltimore, MD | Director T. Rowe Price (1998-2006) Baltimore, MD | Specialist. Education: Loyola University (1997) BA | Finance Sellinger School.

Lance Duncan IV is currently Planning and Analytics Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Securities Industry Financial Market Association (2023) Washington, D.C. | Advocacy & Federal Government Affairs Intern The Fearless Artist (2022-2023) Washington, D.C. | Web 3.0 Community Development Manager Amherst College (2022-2023) Amherst, MA | Teaching Assistant (Economics Department) Mobility Capital Finance (2021) New York, NY | PR & Government Affairs Intern LD4 Technologies (2018-2020) Washington, D.C. | Founder. Education: Amherst College (2024) BA | Economics & Political Science.

Jamison H. Donohue is currently Sr. Planning and Analytics Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Planning and Analytics Associate Hiscox Insurance Group (2020 - 2021) Atlanta, GA | Advanced Analytics Lead Hiscox Insurance Group (2019 - 2020) Atlanta, GA | Associate – Operations and Analytics. Education: Vanderbilt University (2019) BA | Mathematics.

Corinne B. deVito is currently Research Operations Manager, Emerging Markets in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2015. Published career chronology (historical appointments): Sands Capital (2019 - 2024) Arlington, VA | Sr. Executive Assistant Sands Capital (2015 - 2018) Arlington, VA | Executive Assistant U.S. Senate (2011 - 2015) Washington, D.C. | Executive Assistant / Scheduler U.S. House of Representatives (2010 - 2011) Washington, D.C. | Executive Assistant / Scheduler. Education: University of Illinois Urbana-Champaign (2009) BS | Advertising.

Nadia N. Dettman is currently Head of Planning and Analytics in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2008. Published career chronology (historical appointments): Sands Capital (2017 - 2023) Arlington, VA | Director, Planning and Analytics Sands Capital (2016 - 2018) Arlington, VA | Sr. Manager, Planning and Analytics Sands Capital (2014 - 2016) Arlington, VA | Manager, Planning and Analytics Sands Capital (2012 - 2013) Arlington, VA | Sr. Business Initiatives Associate Sands Capital (2011 - 2012) Arlington, VA | Business Initiatives Associate Sands Capital (2008 - 2011) Arlington, VA | Research Associate. Education: Dickinson College (2008) BA | International Business and Management.

Jonathan E. Creem is currently Sr. Trading Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 – 2023) Arlington, VA | Trading & Operational Risk Analyst Internal Revenue Service (2018 – 2021) Washington, D.C. | Economist Bureau of Labor Statistics (2014 – 2018) Washington, D.C. | Economist. Education: University of Connecticut (2014) MA | Economics University of New Haven (2012) BS | Management of Sports Industries, College of Business.

Daniel R. Connolly is currently Controller in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2023 - 2024) Arlington, VA | Director of Accounting Sands Capital (2018 - 2022) Arlington, VA | Manager, Accounting Sands Capital (2016 - 2017) Arlington, VA | Sr. Accounting Systems and Financial Reporting Analyst CrossCountry Consulting (2013 - 2016) McLean, VA | Senior Consultant Deloitte (2009 - 2013) Dublin, Ireland | Audit Senior. Education: University College Dublin (2009) BComm | Accounting.

Andrew Olson became Hercules’ CFO effective May18,2026. He previously held senior finance and operating posts at Revelation Partners, SVB Capital and TriplePoint, and worked at Hercules during 2014–2017. His earlier experience includes PwC; he attended UC Santa Barbara.

Eric Poncin is listed by Wallonie Entreprendre in its current public governance directory as extended executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Marcus joined Novo Holdings A/S in November 2022 as an Associate in Principal Investments. He participates in deal sourcing and execution as well as in managing the existing portfolio. Prior to joining Novo Holdings A/S, Marcus worked as an Associate at FIH Partners focusing on buy-side and sell-side M&A advisory. Marcus holds a BSc in Business Administration & Economics and an MSc in Finance and Accounting from Copenhagen Business School.

Maria joined Novo Holdings A/S in May 2024 as a Business Intelligence Specialist. As part of the Digital team, she is supporting the development of Power BI reporting solutions along with contributing to the enhancement of Business Intelligence initiatives within Novo Holdings. Prior to joining Novo Holdings A/S, Maria worked at Inspari A/S as a Business Consultant. There, her focus was on project management of Data & AI projects as well as designing and developing Data Platforms. Maria holds a MSc in Business Intelligence from Aarhus BSS.

Marcus joined Novo Holdings in December 2024 as a Vice President in Capital Investments. As part of the CI Real Assets team, Marcus is involved in deal sourcing, execution, and portfolio management of real estate investments. Prior to joining Novo Holdings, Marcus has gained real estate experience from working at NREP and most recently at Hines, a global real estate investor and developer, where he primarily focused on direct investments across the Nordic region. Marcus holds a MSc in Finance and Accounting and a BSc in Economics and Business Administration, both from Copenhagen Business School.

Maja joined Novo Holdings in March 2021 as Head of Responsible Investments. Prior to joining Novo Holdings, Maja was employed as Chief ESG Specialist in Danske Bank. Maja additionally brings 10 years of investment experience within external manager selection through previous employments in Danske Bank Asset Management, BankInvest and Industriens Pension. Maja holds an MSc in Finance & Accounting from CBS, Denmark from 2008.

Mason Clark is currently Investment Operations Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): Sands Capital (2023 - 2025) Arlington, VA | Investment Operations Associate New Century Advisors (2022 - 2023) Chevy Chase, MD | Investment Associate Level One Bank (2021) Farmington Hills, MI | Credit Intern. Education: Michigan State University (2022) BA | Finance.

Christopher R. Burrow is currently Sr. Legal Operations Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2023) Arlington, VA | Legal Team Associate. Education: Dickinson College (2020) BA | Economics and Philosophy.

Eliza (Hopkins) Burns is currently Talent Acquisition Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2023) Arlington, VA | Talent Acquisition Coordinator Pact Inc. (2020 – 2022) Washington, D.C. | Sr. Coordinator, Talent Acquisition Metro Systems Inc. (2019 – 2020) Alexandria, VA | Technical Recruiter. Education: Furman University (2019) BA | Communications Studies.

Matthew R. Brezovec is currently Director, Technology in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2016 – 2020) Arlington, VA | Manager, Investment Systems FBR Capital Markets (2011 - 2016) Arlington, VA | V.P. - Co-head Equity Trading Technology FBR Capital Markets (2008 - 2011) Arlington, VA | Director - Trading Technologies FBR Capital Markets (2005 - 2008) Arlington, VA | Business Systems Analyst Deutsche Bank (2005) New York, NY | Trader Deutsche Bank (1999 - 2005) New York, NY | Junior Trader Deutsche Bank (1997 - 1999) Baltimore, MD | Institutional Sales Clerk United States Marine Corps. Education: Norwalk Technical College (2005) AS | Business Administration.

Jessica Bowers is currently Sr. Billing and Financial Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2005. Published career chronology (historical appointments): Sands Capital (2005 - 2015) Arlington, VA | Billing Specialist American Media Services (2002 - 2005) Bethesda, MD | Media Coordinator. Education: University of Maryland (2007) Accounting Certificate The Pennsylvania State University (2002) BS | Business-Marketing.

Maria R. Billups is currently Sr. Investment Operations Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2014 – 2021) Arlington, VA | Reconciliation and Portfolio Administrator Marsico Capital Management, LLC (2004 - 2014) Denver, CO | Trade Operations Specialist Founders Asset Management (2001 - 2004) Denver, CO | Settlements Administrator First Trust Corporation (1999 - 2001) Denver, CO | Datalynx Trader. Education: Community College of Denver (2000) AAS | Computer Information Systems.

Kathryn T. Bickley is currently Director, Portfolio Implementation in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2010. Published career chronology (historical appointments): Sands Capital (2020 - 2021) Arlington, VA | Sr. Manager, Portfolio Implementation Sands Capital (2014 - 2019) Arlington, VA | Portfolio Implementation Manager Sands Capital (2012 - 2014) Arlington, VA | Sr. Portfolio Implementation Specialist Sands Capital (2010 - 2012) Arlington, VA | Portfolio Implementation Specialist U.S. Trust, Bank of America Private Wealth Management (2006 - 2010) Los Angeles, CA | Assistant Vice President, Portfolio Manager Associate Cambridge Associates (2005 - 2006) Arlington, VA | Investment Performance Associate. Education: Washington & Lee University (2005) BS | Business Administration.

Patrick F. Bennett is currently Investment Operations Supervisor in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Sr. Investment Operations Specialist National Philanthropic Trust (2010 –2021) Jenkintown, PA | Senior Investment Operations Manager. Education: Neumann University (2010) BS | Business Administration.

Marc Degaute is listed by Wallonie Entreprendre in its current public governance directory as extended executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Seth Meyer became Hercules’ president effective May18,2026, following service as CFO from 2019. His background includes Swiss Re finance, tax and operations and professional work at PwC and KPMG. He studied accounting and completed an MBA at Michigan State.

Magnus joined Novo Holdings A/S in March 2025 as an Associate in the Planetary Health Investments team. He participates in deal sourcing and execution as well as in managing and developing the growing portfolio of investments. Prior to joining Novo Holdings, Magnus worked in Investment Banking at Danske Bank, focusing on M&A and ECM transactions across various sectors. He previously worked as an Analyst at Polaris Private Equity and FIH Partners. Magnus holds an MSc in Finance and Accounting and a BSc in Economics and Business Administration from Copenhagen Business School.

Mads-Ulrik Kirkebæk is listed by Novo Holdings as Senior Specialist in Finance & Operations. Further biography is not published on the reviewed profile.

Mads joined Capital Investments in January 2025 as an Associate, where he is responsible for analyzing direct investment opportunities. Prior to joining Novo Holdings, Mads gained experience as a management consultant at McKinsey & Company. Mads holds a MSc in Finance and Accounting from Copenhagen Business School.

Mads Holmbom joined Novo Holdings in March 2025 as a Principal in the Planetary Health Investments team. Prior to joining, Mads was a Director in EQT's flagship Private Equity strategy, where he spent six years focused on European large cap buyouts, where he was involved in 9 investments and portfolio companies. At EQT Mads also helped develop and start a number of investment strategies and acquire two other investment firms. Prior to joining EQT, Mads worked at BCG as well as Polaris Private Equity. Mads holds an MSc in Finance and Private Equity from the London School of Economics (LSE) and a BSc in International Business from Copenhagen Business School.

Karl Adams is listed by Wallonie Entreprendre in its current public governance directory as extended executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Ryan E. Bateman is currently Chief Technology Officer, Chief Information Security Officer in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2011. Published career chronology (historical appointments): Sands Capital (2011 - 2019) Arlington, VA | Director, Technology Ipreo (2008 - 2010) New York, NY | Director of Sales and Trading Applications FBR Capital Markets (2004 - 2008) Arlington, VA | Director of Equity Capital Markets Technology FBR International (2001 - 2004) London, England | IT Manager, European Region Friedman Billings Ramsey (1999 - 2001) Arlington, VA | Network Engineer. Education: Georgetown University (2008) MBA | International Business Northwestern University (1998) BA | English Studies.

Mariama S. Bah is currently Sr. Reconciliation Administrator in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2012. Published career chronology (historical appointments): Brown Advisory (2011 - 2012) Baltimore MD | Senior Operations Associate JPMorgan Chase (2010 - 2011) Jersey City, NJ | Performance Analysis Fortigent (2007 - 2009) Rockville, MD | Senior Analyst Barclays Capital (2004 - 2006) New York, NY | Static Data Analyst. Education: University of Maryland (1999) BS | Finance.

Samantha Toler is currently Sr. Director, Business Development and Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2006. Published career chronology (historical appointments): Sands Capital (2006 - 2015) Arlington, VA | Director, Client Relations Goldman Sachs, & Co. (2000 - 2006) New York, NY | Vice President SCA Consulting (1995 - 1998) New York, NY | Consultant Neuberger Berman (1994 - 1995) New York, NY | Portfolio Assistant. Education: New York University (2000) MBA | Stern School of Business Brown University (1994) BA | American Civilization Studies.

Sophia (Stone) Stackhouse is currently Sr. Client Relations and Project Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Client Relations and Project Analyst Sands Capital (2023) Arlington, VA | Sr. Client Relations Associate Sands Capital (2021 - 2022) Arlington, VA | Client Relations Associate Significance, Inc. (2020 - 2021) Alexandria, Virginia | Senior Consultant Fidelity Investments (2019 - 2020) New York City, New York | Associate Financial Analyst Fidelity Investments (2018 - 2019) New York City, New York | Treasury Operations Analyst. Education: Dartmouth College (2018) BS | Sociology.

Louise Sides is currently Client Relations Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Cambridge Associates (2023 - 2025) Arlington, VA | Transaction Services Analyst Ameriprise Financial (2022 - 2023) Minneapolis, MN | Financial Leadership Development Analyst. Education: American University (2022) BS | Finance.

Emily Rueckert is currently Sr. Design and Production Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2025) Arlington, VA | Design and Production Associate Dewberry (2018 - 2022) Fairfax, VA | Desktop Publisher Coworking Solutions (2017 - 2018) Arlington, VA | Operations Manager & Marketing Specialist. Education: Virginia Commonwealth University (2016) BFA | Communication Art, Scientific and Pre-Med Illustration.

Amir Reda is currently Portfolio Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): T. Rowe Price (2021 - 2023) Baltimore, MD | Vice President, Senior Lead Consultant T. Rowe Price (2017 - 2021) Baltimore, MD | Asst. Vice President, Intermediary Consultant T. Rowe Price (2016 - 2017) Baltimore, MD | Intermediary Consultant Calvert Investments (2014 - 2016) Bethesda, MD | Internal Wholesaler Raymond James (2012 - 2014) Rockville, MD | Registered Sales Assistant. Education: St. Mary’s College of Maryland (2011) BA | Political Science.

Matt Pawlak is currently Head of Global Consultant Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Director, Consultant Relations Dimensional Fund Advisors (2012 - 2021) Austin, TX | Vice President, Global Consultant Relations HewittEnnisKnupp, An Aon Company (2003 - 2012) Chicago, IL | Sr. Investment Consultant Allied Tube & Conduit, a Tyco Int'l Company (2001 - 2003) Harvey, IL | Inside Sales Rep. Education: Loyola University Chicago (2009) MBA | Quinlan School of Business The University of Iowa (2001) BA | Economics.

Mads Peter joined Novo Holdings A/S in 2025 as a Venture Partner in the Seed Investments team. Prior to joining Novo Holdings, Mads Peter worked in Novo Nordisk for more than 10 years, initially in various R&D roles in both Denmark and Japan and in recent years in both scientific and financial business development roles, first heading up the BD valuations team and most recently the Global Search & Evaluation team. Other previous employments include Boehringer Ingelheim as well as working some years in the clinic as a medical doctor. Mads Peter holds an MD from Copenhagen University as well as a bachelor in finance from Copenhagen Business School.

Louise joined Novo Holdings in May 2026 as Programme Manager in Strategy and People, where she is part of the Programme and Projects team. Prior to joining Novo Holdings, Louise worked at Novonesis, contributing to the post-merger integration of Chr. Hansen and Novozymes. She has a background in management consulting, strategy execution, digital transformation, and programme management, with prior roles at Novozymes, LEO Pharma and KPMG. Louise holds an MSc in International Business, a BSc in International Business and Politics from Copenhagen Business School, and studied Environmental Economics at Harvard University.

Louise Manniche Rais joined Novo Holdings A/S in December 2025, as an Executive Assistant. She brings a strong background in guest relations and administrative support, having previously worked as a Booking & Guest Relations Manager, Director’s Assistant and Front Desk Supervisor, along with many years of experience as a Receptionist.

Scott Bluestein leads Hercules as chief executive and chief investment officer and also serves on its board. He joined in 2010 as chief credit officer, became CIO in 2014 and CEO in 2019. His earlier career includes Century Tree Capital, Laurus–Valens and UBS; he studied finance at Emory.

Luca Maria Schüpbach joined Novo Holdings A/S as a Senior Strategy Consultant in July 2024. Prior to joining Novo Holdings A/S, Luca Maria first worked as a Senior Associate Consultant at Bain & Company, then as a Health Economist at Einkaufsgemeinschaft HSK. Luca Maria holds a MA degree in Business and Economics from University of Zürich, with a major in Economics and a minor in Data Science.

Laurence Glautier is listed by Wallonie Entreprendre in its current public governance directory as executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Emmett O'Sullivan is currently Sr. Portfolio and Markets Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Portfolio and Market Insights Analyst Stamford Associates (2018 - 2021) Washington, D.C. | Senior Investment Analyst Stamford Associates (2011 - 2018) London, UK | Senior Investment Analyst Investment Association (2008 – 2011) London, UK | Investment Analyst. Education: CASS Business School, London, UK (2008) MSc | Investment Management Dublin City University (2007) BSc | Business Studies.

Stephen F. Nimmo is currently Executive Managing Director, Business Development and Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2010. Published career chronology (historical appointments): Sands Capital (2010 - 2013) Arlington, VA | Head of Business Development, Director, Client Relations Martin Currie Inc. (2008 - 2010) New York, NY | Sr. Client Director Gartmore Investment Management (1997 - 2008) London, UK | European Sales Director The WM Company (1996 - 1997) Edinburgh, UK | European Sales Director The Sedgewick Group Ltd. (1991 - 1996) Edinburgh, UK | Client Director. Education: Durham University (1991) BA | Economics and History.

Kevin G. Murphy is currently Managing Director, Private Wealth in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2002. Published career chronology (historical appointments): Sands Capital (2016 - 2025) Arlington, VA | Sr. Director, Client Relations Sands Capital (2002 - 2015) Arlington, VA | Director, Wealth Management Group, Portfolio Manager Marriott International (1999 - 2001) Washington, D.C. | Sr. Manager, Business Strategy/ Business Analysis Advisory Board Company (1996 - 1997) Washington, D.C. | Marketing Associate Dole/Kemp '96 (1995 - 1997) Washington, D.C. | Sr. Budget Manager Bush/Quayle '92 (1991 - 1993) Washington, D.C. | Compliance Analyst. Education: Georgetown University (1999) MBA | McDonough School of Business Colorado College (1991) BA | Political Science.

Annie K. McCormick is currently Director, Client Service in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2021 - 2023) Arlington, VA | Manager, Client Relations Sands Capital (2017 - 2021) Arlington, VA | Sr. Client Relations Analyst Sands Capital (2014 - 2017) Arlington, VA | Client Relations Analyst Cambridge Associates, LLC (2008 - 2014) Arlington, VA | Team Lead, Investment Performance Analyst. Education: University of Virginia (2025) MBA | Darden School of Business The Pennsylvania State University (2008) BS | Finance.

Jack A. Mayer is currently Director, Portfolio Specialists in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2023) Arlington, VA | Sr. Manager, Portfolio Specialist Sands Capital (2020 - 2022) Arlington, VA | Sr. Portfolio Specialist Sands Capital (2016 - 2020) Arlington, VA | Communications Analyst Morgan Stanley Wealth Management (2014 - 2016) New York, NY | Vice President J.P. Morgan Asset Management (2012 - 2014) New York, NY | Associate J.P. Morgan Private Bank (2009 - 2012) New York, NY | Analyst. Education: College of William & Mary (2009) BA | Economics.

Jamie H. Machak is currently Sr. Client Relations and Business Development Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Sands Capital (2022 - 2023) Arlington, VA | Client Relations Analyst Sands Capital (2020 - 2021) Arlington, VA | Client Relations Associate PNC Bank, N.A. (2017 - 2020) Pittsburgh, PA | VP, Investment Advisor PNC Realty Investors, Inc. (2016 - 2017) Washington, DC | Acquisitions Analyst PNC Bank, N.A. (2015 - 2016) Pittsburgh, PA | Institutional Asset Management Analyst. Education: Duke University (2015) BS | Economics.

Jeff D. Lockhart is currently Head of Client Service in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2011. Published career chronology (historical appointments): Sands Capital (2016 - 2021) Arlington, VA | Director, Client Relations Sands Capital (2014 - 2015) Arlington, VA | Manager, Client Relations Sands Capital (2011 - 2014) Arlington, VA | Sr. Client Service Specialist Bentz Whaley Flessner (2010 - 2011) Arlington, VA | Sr. Research Analyst Cambridge Associates (2003 - 2007) Arlington, VA | Client Services Manager, International Product. Education: Duke University (2009) MBA | Fuqua School of Business Vanderbilt University (2000) BA | Economics.

Josie A. Lewis is currently Managing Director, Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2021 - 2025) Arlington, VA | Sr. Director, Client Relations Sands Capital (2016 – 2020) Arlington, VA | Director, Client Relations Harding Loevner (2005 - 2015) Bridgewater, NJ | Portfolio Manager/Analyst Piti Suksa/Chiang Rai Montessori (2003 - 2004) Chiang Rai, Thailand | Teacher Cambridge Associates (1999 - 2003) Arlington, VA | Senior Consulting Associate ICQ/American Online (1998) Tel Aviv, Israel | Business Associate. Education: University of Maryland (2006) MBA | Finance, Robert H. Smith School of Business Tulane University (1997) BSM | Finance, A.B. Freeman School of Business.

Career 2025 -               President, Greater China, Perkin Elmer, Shanghai 2023 – 2025    Vice President of Commercial Operations, Thermo Fisher Scientific, China 2022 – 2023    Operating Partner, Hillhouse Investment, China 2019 – 2022     President, Life Sciences China, Danaher Corporation, China 2016 – 2019      Vice President/General Manager, Pall Corporation, China 2013 – 2016      Director of Innovation and Growth, Danaher Corporation, China 2012 – 2013      Vice President, International Business Development, Guodian United Power, China Education Bing holds an MBA in Business Administration and Management from the International Institute for Management Development (IMD), Lausanne, Switzerland, an MS in Finance from Boston College, and is a Bachelor of Economics from Sun Yat-sen University, China.

Lone Rask Carlstedt joined Novo Holdings A/S as Event Specialist in October 2024. Prior to joining Novo Holdings A/S, Lone was employed 18 years at Accura law firm working with Client Relations, International Coordination, Administrative Support & Client Services. Other previous employments include Emmerys and SAS.

Line joined Novo Holdings in September 2023. She is Head of Compliance (Europe and Asia) and is responsible for the organisation's compliance programme spanning regulatory obligations across Europe and Asia, including KYC/AML, Conflict of Interest, Insider Trading/MNPI, Data Protection, Whistleblower program and AI governance. Prior to joining Novo Holdings, Line served as Head of Legal & Compliance at BLS Capital Fondsmæglerselskab A/S. She brings more than 20 years of experience from the Danish and international financial sector. Line holds a Master of Laws (LL.M.) from the University of Copenhagen with a specialisation in capital markets law and completed the CBS Executive Board Leadership Education in 2023.

Line joined Novo Holdings A/S in June 2025 as a Director in Strategy Office, part of the Program and Projects team. Prior to joining Novo Holdings A/S, Line worked as a Senior Vice President Strategy, Transformation & M&A in Nexi (former Nets) and as an Associate Partner at McKinsey & Company in Copenhagen. Line holds a MSc in Applied Economics and Finance and a BSc in International Business from Copenhagen Business School.

Sébastien Durieux is listed by Wallonie Entreprendre in its current public governance directory as executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Brendan Leverone is currently Client Relations Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): U.S. Department of Justice, Antitrust Division (2023 - 2025) Washington, D.C. | Paralegal Specialist. Education: Villanova University (2023) BA | Economics.

Naru K. Ji is currently Manager, Product Services in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2012. Published career chronology (historical appointments): Sands Capital (2022 - 2022) Arlington, VA | Supervisor, Client Relations Sands Capital (2018 - 2021) Arlington, VA | Sr. Client Relations Analyst Sands Capital (2012 - 2017) Arlington, VA | Client Relations Analyst Cambridge Associates, LLC (2007 - 2012) Arlington, VA | Sr. Research Associate. Education: Cornell University (2007) BA | Economics.

Satara C. Jethroe is currently Operations Manager, Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): Sands Capital (2023 - 2025) Arlington, VA | Sr. Executive Assistant Sands Capital (2019 - 2022) Arlington, VA | Executive Assistant KBK Enterprises (2014 - 2019) Pittsburgh, PA | Assistant Project Manager. Education: Howard University (2005) BA | Business Administration.

Felicia Haffar is currently Client Relations and Product Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): Sands Capital (2023 - 2025) Arlington, VA | Client Relations Associate Merrill Lynch (2022 - 2023) Boston, MA | Merrill Financial Solutions Advisor Bank of America (2021- 2022) Boston, MA | Advisor Development Program. Education: Smith College (2021) BA | Economics.

Gaby Gramont is currently Digital Marketing Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Digital Marketing Associate TorchLight Hire (2022 - 2023) Alexandria, VA | Marketing Manager TorchLight Hire (2020 - 2022) Alexandria, VA | Marketing Specialist. Education: University of Virginia (2020) BA | Psychology & Media Studies.

Michael P. Gibb is currently Managing Director, Business Development and Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Fidelity International (2018 - 2019) London, UK | Head of Stewardship and Sustainable Investment Martin Currie Investment Management (2005 - 2016) Singapore and Edinburgh, UK | Director CSFB (2000 - 2005) London, UK | Director Salomon Smith Barney (1995 - 1999) London, UK | Vice President Gartmore Investment Management (1994 - 1995) London, UK | Fund Manager Scottish Amicable Investment Managers (1990 - 1994) Glasgow, UK | Portfolio Manager. Education: University of Edinburgh (2017) MBA University of Aberdeen (1990) MA (Hons) | Economic Science.

Samm Fulton is currently Client Relations Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): BBR Partners LLC (2021 - 2022) New York, NY | Associate, Wealth Advisory & Client Services Leith Wheeler Investment Counsel Ltd. (2021) Vancouver, BC | Portfolio Administrator, Pensions & Institutions Park City Capital (2019 - 2020) Philadelphia, PA | Financial Research Analyst. Education: Franklin & Marshall College (2019) BA | Environmental Studies [STEM], Economics.

Angela M.L. Fountain is currently Sr. Executive Assistant in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Executive Assistant Heidrick & Struggles (2017 - 2020) Washington, D.C. | Executive Assistant / Project Manager The Carlyle Group (2007 - 2017) Washington, D.C. | Executive Assistant Spencer Stuart (2003 - 2007) Washington, D.C. | Executive Assistant. Education: Hood College (1993) BA | Biology.

Jean-Pierre Di Bartolomeo is listed by Wallonie Entreprendre in its current public governance directory as executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Laura joined Novo Holdings A/S in October 2025 as a Senior Associate in Principal Investments. She participates in deal sourcing and execution as well as in managing the existing portfolio of investments. Prior to joining Novo Holdings A/S, Laura worked at Montagu Private Equity since 2022, where she was focused on Healthcare investments across DACH, Nordics and the UK. Before that, she spent several years at Morgan Stanley in London and Frankfurt, working in the Healthcare M&A and Equities teams. She holds a BSc in Business Administration from Freie Universität Berlin.

Laura joined Novo Holdings A/S in June 2022 as Senior Legal Counsel and handles various legal matters pertaining to the company, including in relation to investments and divestments as well as general corporate and commercial law matters. Prior to joining Novo Holdings A/S, Laura worked as an associate for almost 5 years with the law firm Gorrissen Federspiel in Copenhagen, specialising in mergers & acquisitions and corporate law. Laura holds a Master of Laws from the University of Copenhagen (2017) and is a member of the Danish Bar Association

Lauren joined Novo Holdings in 2024 as an Associate in the Principal Investments group. Prior to Novo Holdings, Lauren served as an investment banking analyst in the Life Sciences group at Guggenheim Partners for two years. Lauren holds a BS in Neuroscience from the University of Texas at Austin and a MS in Finance from Vanderbilt.

Laura joined Novo Holdings A/S in 2022 as an ESG Specialist in Sustainability & Impact. She supports investment teams and portfolio companies on sustainability matters in due diligence and post-investment.       Prior to joining Novo Holdings A/S, Laura worked in Vækstfonden (now EIFO) as Sustainability Consultant and  previously, as Senior Associate in the impact driven consultancy Nordic Development Corporation with focus on ESG-analysis, sustainability reporting, and strategic project management. Laura holds a BSc in International Business & Politics and a MSc in Applied Economics & Finance from Copenhagen Business School.

Philippe Buelen is listed by Wallonie Entreprendre in its current public governance directory as executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

Mike Degnan is currently Sr. Portfolio Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Portfolio Specialist Fiducient Advisors (2017 – 2022) McLean, VA | Senior Research Analyst Orion Investment Advisors (2015 - 2017) McLean, VA | Director of Research Clark Enterprises, Inc. (2007 - 2015) Bethesda, MD | Research Analyst. Education: University of Maryland (2007) BS | Finance.

Jenny Cline is currently Sr. Executive Assistant in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Executive Assistant VTG (2017 - 2021) Chantilly, VA | EA to the CEO and Executive Team LCC International (2013 - 2016) Tyson’s Corner, VA | EA to the CEO Heinz Endowments (2012 - 2013) Pittsburgh, PA | Program Assistant, Environment The Carlyle Group (2011 - 2012) Washington, D.C. | EA Client Relations. Education: Northern Virginia Community College (2011) BA.

Philip J. Caraci is currently Portfolio Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2023) Arlington, VA | Associate Portfolio Specialist Chevy Chase Trust (2019 - 2021) Bethesda, MD | Associate Director. Education: University of St Andrews (2019) BSc (Hons) | Management.

Jennifer F. Black is currently Director, Business Development Services in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2013. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Sr. Manager, Business Development Services Sands Capital (2022 - 2023) Arlington, VA | RFP Manager Sands Capital (2020 - 2021) Arlington, VA | Portfolio Specialist Sands Capital (2019 - 2020) Arlington, VA | Sr. Client Relations Analyst Sands Capital (2015 - 2018) Arlington, VA | Client Relations Analyst Sands Capital (2013 - 2014) Arlington, VA | Associate Client Service Specialist GW&K Investment Management (2010 - 2013) Boston, MA | Marketing Analyst. Education: University of Richmond (2010) BSBA | Management.

Ian F. Barnes is currently Managing Director, Business Development and Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Veritas Asset Management (2017 - 2020) London | CEO UBS Asset Management (2012 - 2017) London | CEO, Head of U.K. Distribution Russell Investments (2001 - 2012) London | Various roles Towers Perrin (1996 - 2001) London | Investment Consultant. Education: University of Cambridge (1993) MA | Natural Sciences, Social and Political Sciences.

Stephanie C. Aument is currently Sr. Manager, Marketing Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2018. Published career chronology (historical appointments): Sands Capital (2018 - 2022) Arlington, VA | Project Manager Eaton Vance Management (2016 - 2018) Washington, D.C. | IT Project Manager Calvert Investments (2015 - 2016) Bethesda, MD | Director, Information Technology and Research Calvert Investments (2006 - 2015) Bethesda, MD | Senior Analyst and Manager Calvert Investments (2005 - 2006) Bethesda, MD | Research Analyst Investor Responsibility Research Center (1996 - 2000) Washington, D.C. | Senior Analyst. Education: University of Michigan (2002) MBA | Corporate Strategy MS | Natural Resource Policy University of North Carolina at Chapel Hill (1996) BS | Environmental Science.

Matthew B. Alsted is currently Head of Marketing and Communications in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2016 - 2021) Arlington, VA | Director, Portfolio Analysis and Communications Calvert Investments (2004 - 2015) Bethesda, MD | Vice President Riggs Bank (2002 - 2004) Washington, D.C. | Vice President T. Rowe Price (1996 - 2002) Baltimore, MD | Assistant Vice President BayBanks, NA (1994 - 1996) Waltham, MA | Product Development Officer. Education: Babson College (1993) BS | Marketing, International Business.

Stephen P. Zachary is currently Managing Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2016. Published career chronology (historical appointments): Sands Capital (2021 – 2022) Arlington, VA | Partner Sands Capital (2018 – 2021) Arlington, VA | Principal Sands Capital (2018) Arlington, VA | Sr. Associate Sands Capital (2016 - 2017) Arlington, VA | Venture Associate T. Rowe Price (2016) Baltimore, MD | Equity Research Extern Johns Hopkins University (2008 - 2010) Baltimore, MD | Laboratory Technician Dickstein Shapiro LLP (2005 - 2007) Washington, D.C. | Paralegal. Education: Johns Hopkins University PhD | School of Medicine Washington & Lee University BA | Philosophy.

Olivier Bouchat is listed by Wallonie Entreprendre in its current public governance directory as executive committee member. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate. Olivier Bouchat is published in Sambrinvest’s current governance roster. The official Belgian enterprise register corroborates this legal governance appointment, separate from investment-team employment and personal investment attribution.

Lærke joined Novo Holdings A/S in March 2022 as an Associate in Principal Investments. She participates in deal sourcing and execution and manages investments across the healthcare sector as part of the Copenhagen office. Prior to joining Novo Holdings A/S, Lærke worked as an Associate at J.P. Morgan for 4 years, as part of the European Pharma and Biotech Equity Research team, following an investment banking internship at Morgan Stanley. Lærke holds a BSc in Biochemistry from University College London.

Lars joined Novo Holdings A/S in August 2025 as a Senior Financial Controller. He will be participating in the group consolidated reporting and external compliance controlling at the Copenhagen office. Prior to joining Novo Holdings A/S, Lars worked as a Group Financial Controller at Nets/Nexi for 4 years. Before Nets, Lars have been in similar controlling positions regarding external financial reporting and compliance at Nordea, Falck, Novo Nordisk, FLSmidth and Demant. Lars originally holds a background from auditing latest at Ernst & Young combined with a Master of Science Degree in Business Economics & Auditing (CMA) and a Diploma in Economics Financial and Management Accounting (HD – R) from Copenhagen Business School.

Kuang is Vice President in the Seed Investments team where she enjoys infusing a dash of creativity and storytelling into the serious business of venture creation. Prior to Novo Seeds, she spent four years at Sofinnova Partners evaluating clinical-stage investment opportunities and steering portfolio companies through challenges in regulatory pathways, market access, and commercialization.  Kuang holds a Ph.D. in Biochemistry from Indiana University, Bloomington and was recognized with a Clinical and Translational Science Award by the National Institutes of Health (NIH) during her postdoctoral training in the Division of Hematology/Oncology at the University of Michigan.

Member of the Novo Holdings Board since 2025 and appointed Chair of the Board in Nov. 2025. Member of the Novo Holdings Remuneration & Nomination Committee. Lars Green was born in 1967 and is a Danish national. Lars Green began his career as a finance graduate with Novo Nordisk and went on to serve in various leadership positions including group finance and key regional CFO roles in Japan and the U.S. before becoming Executive Vice President in Denmark. He later joined Novozymes as Executive Vice President and CFO, where he led initiatives to streamline the company’s strategy and enhance its commercial biotech focus. His cross-functional experience across the Novo Group brings valuable strategic alignment and continuity to the Novo Holdings Board. Other Board Positions and Management Duties:   Member of the Board of Directors of Novo Nordisk Foundation Member of the Board of Trustees of LEO Foundation and LEO Holdings A/S Member of the Board of directors and Chair of the Audit Committee of LEO Pharma A/S Member of the Board of directors and Chair of the Audit Committee of H. Lundbeck A/S Member of the Board of directors of Pharmacosmos A/S Member of the Board of directors of Nordic Storm A/S

Olivier Vanderijst is listed by Wallonie Entreprendre in its current public governance directory as executive committee chair. This is a governance affiliation with the regional public investment group rather than evidence of personal investment capital or a specific company board mandate.

George Severiades is registered by the Belgian KBO as a director of Stimalia, enterprise1026.843.681, from April23,2026. His precise operating role, portrait and investment ticket are not established by the statutory appointment.

Stanton Rowe is registered by the Belgian KBO as a director of Stimalia, enterprise1026.843.681, from May28,2026. The statutory appointment does not by itself establish an operating employment, cash investment or portrait identity.

Sylvain d’Amico is Stimalia’s Chief Commercial Officer and co-founder. The company describes his experience in neurovascular and cardiovascular innovation at Boston Scientific, Edwards Lifesciences, Stryker and Penumbra. His company affiliation is distinct from people with similar surnames; the public directory does not establish an exact appointment date.

Olivier Ménage is Stimalia’s CEO and co-founder. Its official directory describes his experience in medical devices, neuromodulation, minimally invasive surgery and digital health, including founding MONA.health and previously leading Man&Science. The Belgian KBO registers him as a director from August26,2025 and delegated director from May27,2026.

Christy Steele is currently Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Sands Capital (2022 - 2025) Arlington, VA | Principal Sands Capital (2020 - 2021) Arlington, VA | Sr. Associate Firebrand Strategy (2016 - 2020) Washington, D.C. | Owner, Media Producer Science Magazine (2015 - 2016) Washington, D.C. | Senior Photo Editor Smithsonian Channel (2014 - 2015) Washington, D.C. | Associate Producer. Education: Georgetown University (2020) MBA | McDonough School of Business Georgetown University (2006) BA | English.

Erin Soule is currently Managing Director, Head of Alternatives Finance and Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): American Capital, Ltd. (2006 - 2013) Bethesda, MD | Vice President American Capital, Ltd. (2001 - 2005) Bethesda, MD | Senior Manager PricewaterhouseCoopers, LLP (1996 - 2001) New York, NY & Washington, D.C. | Senior Associate. Education: The College of New Jersey BS | Accountancy.

Shreya Singh is currently Sr. Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2023 - 2025) Arlington, VA | Associate A-Level Capital (2019 - 2022) Baltimore, MD | Managing Partner Neurodata.io (2021 - 2022) Baltimore, MD | Graduate Researcher. Education: Johns Hopkins University (2022) MS | Biomedical Engineering, Biomedical Data Science Johns Hopkins University (2021) BS | Biomedical Engineering, Biomedical Data Science.

Aagam Shah is currently Principal in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Sr. Associate Sands Capital (2022 - 2023) Arlington, VA | Associate OCCIDENT Group AG (2021 - 2022) Zug, Switzerland | Investment Analyst – Life Sciences ETH Zurich (2014 - 2020) Zurich, Switzerland | Graduate Research Assistant Massachusetts Institute of Technology (2014 - 2015) Cambridge, MA | Research Support Associate III. Education: ETH Zurich (2020) PhD | Information Technology & Electrical Engineering Johns Hopkins University (2014) MSE | Biomedical Engineering University of Mumbai (2011) BE | Biomedical Engineering.

Kshitij Seth is currently Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2023. Published career chronology (historical appointments): G Squared (2021 - 2023) San Francisco, CA | Associate. Education: University of California, Berkeley (2020) BS | Mechanical Engineering.

Marina Serenbetz is currently Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Steadfast Financial LP (2014 - 2022) New York, NY | Portfolio Manager, Sector Head Goldman Sachs (2012 - 2014) New York, NY | Investment Banking Analyst. Education: University of Virginia (2012) BS | Commerce BA | Spanish.

Alexander J. Schelhorn is currently Sr. Associate, Alternatives Finance and Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): GCM Grosvenor LP (2023-2025) Chicago, IL | Associate GCM Grosvenor LP (2022-2023) Chicago, IL | Analyst KPMG US LLP (2021-2022) Chicago, IL | Senior Associate KPMG US LLP (2019-2021) New York, NY | Associate. Education: University of Notre Dame (2019) MSA | Accountancy University of Notre Dame (2018) BBA | Accountancy.

Miriam Z. Sanders is currently Director, Investor Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2022) Arlington, VA | Manager, Investor Relations Blackstone (2020 - 2021) Washington, DC | Director Blackstone (2017 - 2020) New York, NY | Assistant Vice President Blackstone (2014 - 2017) New York, NY | Manager Blackstone (2013 - 2014) New York, NY | Analyst Barclays Capital (2011 - 2013) New York, NY | Analyst. Education: The University of North Carolina Wilmington (2011) BS | Finance.

Kirill joined Novo Holdings A/S in August 2023 as a Senior Financial Data Specialist in Finance & Operations. He is responsible for Simcorp Dimension, the platform used for investment management at Novo Holdings. Before joining Novo Holdings, Kirill was employed in various Middle and Back Office positions in asset management firms and pension funds. He has 7 years of track within Simcorp Dimension and with investment processes and calculations. He also has experience working with Bloomberg data and other financial data systems. Kirill holds an MSc in Economics.

Krista Søndergaard joined Novo Holdings A/S as Personal Assistant in Principal Investments in August 2022. Prior to joining Novo Holdings, Krista was employed as an EA at Nordstern.  Other previous employments include Coordinator at Novo Nordisk, Finance business Partner at Haldor Topsøe and as Technical Accountant at Swiss Re. Krista holds a Graduate Certificate in business Administration from Copenhagen Business School.

Kristian joined Capital Investments in July 2022 as a Senior Associate, where he is responsible for analysing direct public investment opportunities. Kristian joined Novo Holdings in June 2020 as a valuation specialist in Finance & Operations. Prior to joining Novo Holdings, Kristian worked as a consultant in PwC’s Deals team and as an equity analyst in SparKron’s Markets team. Kristian holds a MSc in Finance & International Business from Aarhus University.

Kristen joined Novo Holdings in 2022 and is the Office Manager for the Boston office. Before joining Novo Holdings, she worked as an elementary school teacher in Massachusetts. Kristen received a Bachelor of Arts degree from Curry College and a Masters of Art in Teaching degree from University of North Carolina Wilmington.

Amanda E. Roberts is currently Associate Director, Business Development and Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Manager, Client Relations and Business Development Sands Capital (2021 - 2023) Arlington, VA | Business Development Associate Sands Capital (2018 – 2020) Arlington, VA | Business Development and Client Relations Coordinator Sands Capital (2015 – 2018) Arlington, VA | Client Relations Coordinator Sands Capital (2014 – 2015) Arlington, VA | Client Relations Assistant Capital Group Companies (2011 - 2013) Washington, D.C. | Investment Group Research Assistant Penzance (2010 - 2011) Washington, D.C. | Executive Assistant. Education: University of California, Davis (2009) BA | Economics.

Gene Riechers is currently Venture Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): COFENSE (2018 - 2021) Leesburg, VA | Director MorganFranklin Consulting (2016 - 2017) McLean, VA | Senior Advisor EverFi (2012 - 2017) Washington, DC | Vice Chairman Opower (2011 - 2016) Arlington, VA | Director Valhalla Partners (2002 - 2011) Vienna, VA | General Partner webMethods (1997 - 2004) Location, Location | Director FBR Technology Venture Partners (1996 - 2002) Arlington, VA | Managing Director. Education: Loyola University of Maryland MBA Penn State University BS.

Glenna Perry is currently Manager, Alternatives Finance and Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2025) Arlington, VA | Fund Accounting Manager PwC (2021 - 2022) Washington, D.C. | Manager PwC(2018 - 2021) Washington, D.C. | Senior Associate PwC (2016 - 2018) Washington, D.C. | Associate. Education: Tulane University (2016) MACCT | Accounting Tulane University (2016) BSM | Finance.

Tyler Miller is currently Manager, Alternatives Finance and Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): Sands Capital (2022 – 2023) Arlington, VA | Sr. Finance & Operations Associate Sands Capital (2019 – 2021) Arlington, VA | Finance & Operations Associate PwC (2016 - 2018) McLean, VA | Risk Assurance Associate. Education: Georgetown University (2016) BA | Economics.

Jake Merrill is currently Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2022 - 2025) Arlington, VA | Principal Sands Capital (2018 - 2021) Arlington, VA | Sr. Associate Sands Capital (2017 - 2018) Arlington, VA | Sr. Research Associate Causeway Capital (2016 - 2017) Los Angeles, CA | Research Analyst Sands Capital (2014 - 2016) Arlington, VA | Research Associate. Education: University of Virginia BS | McIntire School of Commerce.

Mark McGovern is currently Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Ravenwill (2019 - 2021) Orlando, FL | CEO CA Technologies (2016 – 2019) Washington, DC | Vice President, Product Management Mobile System 7 (2011 - 2016) Bethesda, MD | CEO, Co-Founder In-Q-Tel (2002 - 2011) Arlington, VA | Vice President, Technology Cigital (2000 - 2002) Herndon, VA | Director, Technology. Education: Virginia Tech MS | Engineering Worcester Polytechnic Institute BS | Electrical Engineering.

Morgan Lee is currently Director, Sr. Counsel in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 – 2024) Arlington, VA | Legal Counsel Goodwin Procter LLP (2021 - 2022) Washington, DC | Associate Davis Polk & Wardwell LLP (2015 - 2021) New York, NY | Associate Finnegan, Henderson, Farabow, Garrett & Dunner, LLP (2009 - 2012) Washington, DC | Practice Support Services Assistant. Education: Columbia Law School (2015) Juris Doctor Princeton University (2008) AB | History.

Namita Kumari is currently Associate, Technical Research in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): Centre for Nanoscience and Engineering (2017 - 2023) Bangalore, Karnataka | Senior Research Scientist University of Zurich (2014 - 2016) Zurich, Switzerland | Research Associate Indian Institute of Science (2012 - 2014) Bangalore, Karnataka | Junior Research Associate. Education: Indian Institute of Science (2013) PhD | Organic Chemistry Indian Institute of Technology Roorkee (2007) MS | Chemistry.

Joanne Hwang is currently Executive Assistant in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): US-ASEAN Business Council (2016 - 2019) Washington, D.C. | EA to President & CEO FBR & Co. (2014 - 2016) Arlington, VA | Administrative Assistant. Education: University of Florida BS | Recreation, Parks and Tourism.

Brad Howlett is currently Director, Alternatives Finance and Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2015. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Sr. Manager, Finance & Operations Sands Capital (2019 - 2020) Arlington, VA | Manager, Finance & Operations Sands Capital (2015 - 2019) Arlington, VA | Financial Analyst Baker Tilly Virchow Krause, LLP (2011 - 2015) Tysons Corner, VA | Senior Consultant. Education: University of Virginia MS | Data Science (2021) BS | Commerce.

Scott Headd is currently Managing Director, Business Development and Client Relations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: Re-joined in 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2025) Arlington, VA | Sr. Director, Client Relations J.P. Morgan (2012 – 2021) Washington, D.C. | Managing Director Sands Capital (2011) Arlington, VA | Research Intern FBR Capital Markets (2005 - 2010) Arlington, VA | Vice President. Education: University of Virginia (2012) MBA | Darden School of Business University of Virginia (2005) BA | McIntire School of Commerce.

Abby Hadlock is currently Sr. Associate, Alternatives Finance and Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2026. Published career chronology (historical appointments): CFGI (2023 - 2025) Washington, D.C. | Lead Consultant Carter Mackenzie International (2021 - 2023) Washington, D.C. | Staff Consultation. Education: Johns Hopkins University (2024) MS | Environmental Science and Policy College of the Holy Cross (2021) BA | English.

Michael Graninger is currently Managing Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2018. Published career chronology (historical appointments): Sands Capital (2018 - 2022) Arlington, VA | Partner In-Q-Tel (2014 - 2018) Arlington, VA | Partner Mobile System 7 (2013 - 2014) Arlington, VA | President, Co-Founder In-Q-Tel (2003 - 2013) Arlington, VA | Partner The Hunter Capital Group (2001 - 2003) Columbia, MD | Managing Director Friedman, Billings, and Ramsey (1997 - 2001) Arlington, VA | Senior Vice President. Education: San Diego State University MBA Salisbury State University BS | Business Administration.

Amanda Golden is currently Sr. Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Google (2021 - 2023) Washington, D.C. | News Communications Manager NBC News (2019 - 2021) Washington, D.C. | Political Reporter CNN (2017 - 2019) Washington, D.C.| Associate Producer NBC Nightly News (2016 - 2017) New York, NY | Desk Assistant NBCUniversal (2015 - 2016) New York, NY | NBC Page Program. Education: University of Virginia (2025) MBA | Darden School of Business Colgate University (2015) BA | Political Science.

Andrew P. Giordano is currently Executive Managing Director, Client Relations and Business Development in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2010. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Managing Director, Client Relations, and Business Development Sands Capital (2020 - 2021) Arlington, VA | Sr. Director, Client Relations Sands Capital (2015 - 2019) Arlington, VA | Director, Client Relations Sands Capital (2012 - 2014) Arlington, VA | Manager, Client Relations Sands Capital (2010 - 2012) Arlington, VA | Wealth Management Associate Friedman, Billings, Ramsey Capital Markets (2008 - 2010) Arlington, VA | Vice President Friedman, Billings, Ramsey Capital Markets (2006 - 2008) Arlington, VA | Associate. Education: Columbia University & London Business School (2016) Dual MBA Middlebury College (2004) BA | International Politics and Economics.

Michael J. Ginder is currently Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2011. Published career chronology (historical appointments): Sands Capital (2021 - 2022) Arlington, VA | Principal, Research Analyst Sands Capital (2017 - 2021) Arlington, VA | Research Analyst Sands Capital (2014 - 2016) Arlington, VA | Sr. Research Associate Sands Capital (2011 - 2013) Arlington, VA | Research Associate. Education: University of Virginia (2011) BS | McIntire School of Commerce.

Kim Jialing Png is listed by Novo Holdings as Partner in Seed Investments, Novo Holdings Asia. Further biography is not published on the reviewed profile.

Andrew Gavlin is currently Vice President in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2018. Published career chronology (historical appointments): Sands Capital (2022 - 2023) Arlington, VA | Sr. Research Associate Sands Capital (2018 – 2021) Arlington, VA | Research Associate. Education: Washington & Lee University (2018) BS | Accounting and Business Administration BS | Political Philosophy.

Kumar Gautam is currently Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: Rejoined in 2020. Published career chronology (historical appointments): Sands Capital (2020 - 2022) Arlington, VA | Research Analyst, Principal Sands Capital (2017 - 2020) Arlington, VA | Principal Sands Capital (2016 - 2017) Arlington, VA | Sr. Associate Sands Capital (2014 - 2015) Arlington, VA | Venture Analyst Altman Vilandrie (2011 - 2014) Boston, MA | Senior Analyst. Education: Stanford University (2020) MS | Graduate School of Business Dartmouth College (2011) BA | Computer Science.

Jane Fellowes is currently Sr. Manager, Alternatives Finance and Operations in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Sands Capital (2020 - 2024) Arlington, VA | Fund Accounting Manager Madison Marquette (2017 - 2020) Washington, D.C. | Portfolio Accounting Manager Baker Tilly Virchow Krause, LLP (2015 - 2017) Tysons, VA | Senior Accountant. Education: Virginia Tech (2015) BS | Accounting and Information Systems.

Christopher Eng is currently Partner in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): Sands Capital (2021 - 2025) Arlington, VA | Principal Sands Capital (2019 – 2020) Arlington, VA | Sr. Associate YL Ventures (2018 - 2019) Chicago, IL | Venture Associate Forgepoint Capital (2018) San Mateo, CA | Summer Associate Origin Ventures (2017 – 2018) Chicago, IL | Venture Capital Fellow Merlon Intelligence (2017) Washington, D.C. and Chicago, IL | Business Operations Manager Promontory Financial Group (2012 - 2017) Washington, D.C. | Associate, Product Manager. Education: University of Chicago MBA | Booth School of Business Georgetown University BS | Foreign Service in International Economics.

Phoebe J. Cooke is currently Sr. Executive Assistant in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2023 - 2025) Arlington, VA | Executive Assistant FODIS (Family Office Direct Investment Services) (2017 – 2022) Senior Associate, Administrations & Operations AES Corporation (2015 - 2017) Arlington, VA | Executive Assistant, Global Finance Operations & Investor Relations Columbia Property Trust (2014 - 2015) Washington D.C. | Executive Assistant & Office Manager Headwaters | SC (2012 - 2014) Pittsburgh, PA | Associate, Marketing & Business Development Royal Bank of Scotland (2009 - 2012) Stamford, CT | Executive Assistant, Syndicate High Yield & Loan. Education: Norwalk Community College BA Borough of Manhattan Community College BA.

Padmaparna Chaudhuri is currently Director of Technical Research in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Farcast Biosciences (2017-2020) Bangalore, India | Director R&D, Intellectual Property General Electric (2010 - 2017) Bangalore, India | Lead Intellectual Property Professional Brigham & Women’s Hospital, Harvard-MIT Division of Health Science and Technology (2007 - 2010) Cambridge, MA | Post-doctoral fellow. Education: Indian Institute of Science (2007) PhD | Organic Chemistry Indian Institute of Science (2002) MS | Chemical Sciences.

T. Perry Williams is currently President Chief Investment Officer in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2004. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | President, Sr. Portfolio Manager Sands Capital (2016 - 2023) Arlington, VA | President, Director of Research, Sr. Portfolio Manager Sands Capital (2015) Arlington, VA | Director of Research, Sr. Portfolio Manager, Research Analyst, Executive Managing Director Sands Capital (2011 - 2014) Arlington, VA | Sr. Portfolio Manager, Research Analyst, Executive Managing Director Sands Capital (2011) Arlington, VA | Sr. Portfolio Manager, Research Analyst, Managing Director Sands Capital (2006 – 2010) Arlington, VA | Portfolio Manager, Research Analyst. Education: Northwestern University (1999) MBA | Kellogg Graduate School of Management University of Virginia (1994) BS | McIntire School of Commerce.

Jerry Wang is currently Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Education: Yale University (2022) MMS | School of Management Georgetown University (2020) BA | Economics.

Thomas H. Trentman is currently Sr. Portfolio Manager Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2005. Published career chronology (historical appointments): Sands Capital (2017 - 2020) Arlington, VA | Portfolio Manager, Sr. Research Analyst Sands Capital (2011 - 2016) Arlington, VA | Portfolio Manager, Research Analyst Sands Capital (2008 - 2010) Arlington, VA | Research Analyst Sands Capital (2005 - 2008) Arlington, VA | Research Associate. Education: Washington & Lee University (2005) BS | Physics-Engineering BA | Chemistry.

Jery Tang is currently Sr. Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Research Associate Canaccord Genuity (2020 - 2021) New York, NY | Investment Banking Analyst. Education: New York University (2020) BS | Stern School of Business.

Jessica Sun is currently Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Harvest Fund Management Co. (2021 - 2024) Beijing, CN | Research Analyst Altice USA (2017 - 2020) New York, NY | Global Apprentice, FP&A Telligent Capital Management (2011 - 2015) Hong Kong, HK | Investment Research Analyst. Education: Yale University (2017) MBA | School of Management The Chinese University of Hong Kong (2011) BS | Quantitative Finance (Hons).

Sam Stalfort is currently Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): Sands Capital Arlington, Virginia | Summer Intern Lumar (formerly Deepcrawl) Charlottesville, Virginia | Business Development Summer Associate. Education: University of Virginia BS | McIntire School of Commerce, Finance Concentration.

Frank M. Sands is currently Chief Executive Officer Chief Investment Officer in Sands Capital’s published firmwide directory. The biography records joining or rejoining: Re-joined in 2000. Published career chronology (historical appointments): Sands Capital (2004 - 2008) Arlington, VA | President, Director of Research Sands Capital (2000 - 2004) Arlington, VA | Managing Director, Director of Research, Sr. Portfolio Manager Fayez Sarofim & Co. (1994 - 2000) Houston, TX | Research Analyst, Portfolio Manager, Principal Sands Capital (1992) Arlington, VA | Assistant to the President Walker & Dunlop (1989 - 1991) Washington, D.C. | Commercial Real Estate Leasing and Sales. Education: University of Virginia (1994) MBA | Darden School of Business Johns Hopkins University (1993) MS | Real Estate Finance & Development Washington & Lee University (1989) BA | Economics.

Thomas A. Rogers is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2017 - 2025) Arlington, VA | Research Analyst Sands Capital (2016 - 2019) Arlington, VA | Sr. Research Associate Sands Capital (2014 - 2016) Arlington, VA | Research Associate Strategic Investment Group (2013 - 2014) Arlington, VA | Investment Analyst. Education: University of Virginia (2013) MS | McIntire School of Commerce William & Mary (2012) BA | Economics.

Kelly L. Rogal is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): Wafra (2022 - 2024) New York, NY | Director Franklin Templeton (2017 - 2022) San Francisco, CA | Analyst/Portfolio Manager BNP Paribas Corporate & Investment Bank (2016 - 2017) New York, NY | Analyst Oak Hill Advisors (2014 - 2016) New York, NY | Associate Falcon Point Capital (2009 - 2013) San Francisco, CA | Associate. Education: University of California, Berkeley (2008) BA | Slavic Languages and Area Studies.

Karin Riechenberg is currently Director of Stewardship in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Sands Capital (2021 - 2022) Arlington, VA | Sr. ESG Analyst Sands Capital (2020 - 2021) Arlington, VA | ESG Analyst Cartica Management (2018 - 2020) Washington, D.C. | Senior ESG Analyst Cartica Management (2016 - 2018) Washington, D.C. | Senior Global Strategy Analyst Deloitte CIS (2015 - 2016) Moscow, Russia | Alfa Fellow Cartica Management (2014 - 2015) Washington, D.C. | Associate, ESG and Global Strategy. Education: Johns Hopkins University (2014) MA | International Economics and International Relations, School of Advanced International Studies University of Exeter (2012) BA | International Relations and Russian.

Michael F. Rallo is currently Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2019. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Sr. Research Associate Sands Capital (2019 - 2021) Arlington, VA | Research Associate Houlihan Lokey (2018 - 2019) McLean, VA | Investment Banking Analyst. Education: Washington and Lee University (2018) BS | Accounting and Business Administration.

Michael F. Raab is currently Director of Research Portfolio Manager Sr. Research Analyst Executive Managing Director in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2007. Published career chronology (historical appointments): Sands Capital (2024) Arlington, VA | Director of Research, Portfolio Manager, Sr. Research Analyst Sands Capital (2021 – 2023) Arlington, VA | Portfolio Manager, Sr. Research Analyst Sands Capital (2019 – 2021) Arlington, VA | Portfolio Manager, Sr. Research Analyst, Associate Director of Research Sands Capital (2017 - 2019) Arlington, VA | Sr. Research Analyst, Associate Director of Research Sands Capital (2015 - 2016) Arlington, VA | Research Analyst, Associate Director of Research Sands Capital (2010 – 2015) Arlington, VA | Research Analyst Sands Capital. Education: University of Maryland (2011) MBA | Robert H. Smith School of Business University of Virginia (2006) BA | Economics.

Daniel Pilling is currently Portfolio Manager Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2018. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Sr. Research Analyst Sands Capital (2018 - 2021) Arlington, VA | Research Analyst Balyasny Asset Management (2015 - 2017) New York, NY | Analyst Millennium Capital Partners (2014 - 2015) London, UK | Analyst QVT Financial (2012 - 2014) London, UK | Analyst Fidelity (2010 - 2011) London, UK | Research Associate Greenhill & Co. (2007 - 2009) London, UK | Analyst. Education: Cambridge University (2007) MPhil | Finance Manchester Business School (2006) BA | Business Finance and Economics.

Jerry Peng is currently Global Strategy Officer in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2017. Published career chronology (historical appointments): Green Entrepreneurship (2013 - 2017) Virginia, US | Founder & CEO Goldman Sachs (2009 - 2012) Hong Kong, China | Managing Director, Securities Division & Investment Banking Division Morgan Stanley (2007 - 2009) Beijing, China | Executive Director, Head of China Onshore Sales & China Corporate Sales, Fixed Income Division Standard Chartered Bank (2004 - 2007) Beijing, China | Director and Senior Vice President, Head of Corporate Banking, China Franchise Bank One (2000 - 2001) Beijing, China | Senior Relationship Manager, China Corporate Aviation Industry. Education: University of Virginia (2003) MBA | Darden School of Business Beijing University of Aeronautics & Astronautics (1995) Bachelors | Finance-Engineering.

Ashley N. Patton is currently Sr. Stewardship Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2025) Arlington, VA | Stewardship Analyst Sands Capital (2023 - 2024) Arlington, VA | ESG Analyst Sands Capital (2021 - 2023) Arlington, VA | ESG Communications Analyst Public Company Accounting Oversight Board (2021) Washington, D.C. | Senior International Policy Analyst Public Company Accounting Oversight Board (2017 - 2021) Washington, D.C. | International Policy Analyst Department of Justice (2013 - 2015) Washington, D.C. | Paralegal, Foreign Corrupt Practices Act Unit A.B. Data, Ltd. (2011 - 2013) Washington, D.C. | Account Assistant. Education: Johns Hopkins University (2017) MA | International Economics and International Relations, School of Advanced International Studies University of North Carolina at Chapel Hill (2011) BA | Political Science and Global Studies.

Danielle Menichella is currently Portfolio Manager Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2013. Published career chronology (historical appointments): Sands Capital (2020 – 2020) Arlington, VA | Portfolio Manager, Research Analyst Sands Capital (2013 – 2020) Arlington, VA | Research Analyst Ashmore Equity Investment Management (2010-2013) Arlington, VA | Senior Analyst Emerging Markets Management (1997-2010) Arlington, VA | Analyst. Education: Duke University (1997) AB | Economics and Public Policy.

Barron B. Martin Jr. is currently Managing Partner Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2008. Published career chronology (historical appointments): Sands Capital (2011 - 2017) Arlington, VA | Research Analyst Sands Capital (2011) Arlington, VA | Sr. Research Associate Sands Capital (2008 - 2010) Arlington, VA | Research Associate. Education: Washington & Lee University (2008) BS | Business Administration BA | Geology.

Jax Malloy is currently Sr. Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2021 - 2024) Arlington, VA | Research Associate. Education: Babson College (2020) BS | Business Administration.

Katrine joined Novo Holdings in 2026 as Programme Manager in the Strategy Office, where she is part of the Programme and Projects team. Prior to joining Novo Holdings, Katrine held a Strategy Lead role at Novo Nordisk's Executive Office, where she drove strategy execution, governance structuring, and organisational transformation. She brings cross-sector experience as a strategic advisor and project manager spanning the legal, financial, pharmaceutical, and media intelligence sectors. Katrine holds an MSc in International Marketing and Management from Copenhagen Business School.

Katrine joined Novo Holdings as an Associate in Capital Investments in August 2022. She is part of the Real Assets team, focuses on investments in Real Estate and Infrastructure, and participates in deal sourcing and execution, as well as managing the existing portfolio. During her studies, Katrine worked as a Junior Analyst at Novo Holdings and at KIRKBI, also focusing on the real estate and infrastructure sector. Katrine holds a MSc in Finance and Accounting and a BSc in International Business, both form Copenhagen Business School.

Matthew W. Luneburg is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2006. Published career chronology (historical appointments): Sands Capital (2009 - 2020) Arlington, VA | Research Analyst Sands Capital (2006 - 2009) Arlington, VA | Research Associate. Education: Washington & Lee University (2006) BA | Economics.

David E. Levanson is currently Sr. Portfolio Manager Research Analyst Executive Managing Director in Sands Capital’s published firmwide directory. The biography records joining or rejoining: Re-joined in 2002. Published career chronology (historical appointments): Sands Capital (2002 - 2006) Arlington, VA | Research Analyst, Portfolio Manager MFS Investment Management (1999 - 2002) Boston, MA | Research Analyst State Street Research & Management (1996 - 1999) Boston, MA | Research Analyst, Vice President Sands Capital (1992 - 1994) Arlington, VA | Research Analyst The Capital Management Group Folger Nolan Fleming Douglas (1990 - 1992) Washington, D.C. | Research Analyst. Education: University of Virginia (1996) MBA | Darden School of Business University of Florida (1990) BSBA | Finance.

Joon Lee is currently Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Wells Fargo (2023 - 2025) New York, NY | Investment Banking Analyst. Education: University of Virginia (2023) BS | McIntire School of Commerce.

Eduardo Leal is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Research Analyst STK Capital (2010 - 2020) Rio de Janeiro, Brazil | Partner/Head of Equity Research Platina Investimentos (2008 - 2010) Rio de Janeiro, Brazil | Equity Research Analyst. Education: Stanford Graduate School of Business (2021) MS | Management Pontifícia Universidade Católica do Rio de Janeiro (2008) BA | Industrial Engineering.

Saeyeon Kwon is currently Research Associate, Stewardship in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): Sands Capital (2024) Arlington, VA | ESG Intern. Education: Georgetown University (2024) MS | Environment and Sustainability Management George Mason University (2022) BA | Global Affairs.

Daniel Khazanov is currently Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): EY-Parthenon (Software Strategy Group) (2023) Boston, MA | Summer Associate Collective[i] (2021-2022) New York, NY | Product Intern. Education: Swarthmore College (2024) BA | Cognitive Science and Russian.

Brian X. Keegan is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2011. Published career chronology (historical appointments): Sands Capital (2017 - 2025) Arlington, VA | Research Analyst Sands Capital (2014 - 2016) Arlington, VA | Sr. Research Associate Sands Capital (2011 - 2013) Arlington, VA | Research Associate. Education: Washington and Lee University (2011) BA | Economics and Politics.

Jacob H. Kann is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): T. Rowe Price (2013 - 2025) Baltimore, MD | Investment Analyst, VP Eaton Vance (2010 - 2013) Boston, MA | Investment Associate. Education: Columbia University (2016) MBA | Columbia Business School Brandeis University (2009) BA | Economics.

Katja Utzon Lindgreen is listed by Novo Holdings as Specialist in Finance & Operations. Further biography is not published on the reviewed profile.

Kasim Kutay is Chief Executive Officer of Novo Holdings A/S, Denmark, a position he has held since September 1, 2016. In addition, Kasim is a member of the Board of Directors of Novo Nordisk A/S and Novonesis A/S. From 2009 to 2016 Kasim was a Partner and member of the Global Management Committee of Moelis & Co. From 1989 to 2007 Kasim held a number of positions at Morgan Stanley, including chair of the European Healthcare Group. Kasim was member of the Board of Trustees of Northwick Park Institute for Medical Research, UK, from 2005 to 2016. Kasim was member of the Board of Governors from 2006 to 2011 and the Investment Committee from 2011 to 2016 of the School of Oriental and African Studies (SOAS), UK. Kasim is a member of the Board of CW+, Chelsea and Westminster Hospital NHS Foundation Trust. Kasim is a UK national and holds a MSc. and BSc. in Economics from the LSE (London School of Economics and Political Science).

Wesley A. Johnston is currently Sr. Portfolio Manager Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2004. Published career chronology (historical appointments): Sands Capital (2016 - 2020) Arlington, VA | Portfolio Manager, Sr. Research Analyst Sands Capital (2009 - 2015) Arlington, VA | Sr. Research Analyst Sands Capital (2006 - 2008) Arlington, VA | Research Analyst Sands Capital (2004 - 2006) Arlington, VA | Research Associate. Education: University of Pennsylvania (2002) BS | Economics.

Christopher S. Jenkins is currently Sr. Proxy and Stewardship Specialist in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2017. Published career chronology (historical appointments): Sands Capital (2024 - 2025) Arlington, VA | Sr. Proxy Specialist Sands Capital (2022 - 2023) Arlington, VA | Proxy Specialist Sands Capital (2017 - 2021) Arlington, VA | Investment Operations Specialist The Edgar Lomax Company (2013 - 2017) Springfield, VA | Investment Operations Specialist United States Marine Corps (2005 - 2013) Camp Pendleton, CA | Sergeant. Education: George Mason University (2018) MBA | Costello College of Business George Mason University (2013) BS | Finance.

Chitrank Jain is currently Sr. Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2024. Published career chronology (historical appointments): Avendus Spark (2020 - 2024) Mumbai, India | Director – Equity Sales Motilal Oswal (2015 - 2020) Mumbai, India | Vice President – Equity Sales Kotak Mahindra Bank (2011 - 2013) Mumbai, India | Senior Manager – Internal Audit. Education: S.P. Jain Institute of Management & Research, Mumbai (2015) PGDM (MBA) | Finance The Institute of Chartered Accounts of India, New Delhi (2010) Associate Chartered Accountant.

Zhaoqi Huang is currently Sr. Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2022. Published career chronology (historical appointments): Sands Capital (2022 - 2024) Arlington, VA | Research Associate Deloitte Consulting, LLP (2021 - 2022) Washington, D.C. | Healthcare Consultant Deloitte Consulting, LLP (2019 - 2021) Washington, D.C. | Healthcare Business Technology Analyst. Education: Pomona College (2019) BA | Molecular Biology.

Stephanie He is currently Sr. Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): UBS Securities (2024 - 2025) New York, NY | Equity Research Associate Deutsche Bank (2017 - 2022) New York, NY | Associate. Education: Columbia University (2024) MBA | Columbia Business School Emory University (2017) BA | Economics and Mathematics.

Christina Hang is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2018. Published career chronology (historical appointments): Sands Capital (2021 - 2025) Arlington, VA | Research Analyst Sands Capital (2018 - 2020) Arlington, VA | Sr. Research Associate Dodge & Cox (2016 - 2018) San Francisco, CA | Sr. Research Associate Dodge & Cox (2014 - 2016) San Francisco, CA | Research Associate Navigant Economics (formerly AFE Consulting) (2012 - 2014) Oakland, CA | Research Analyst. Education: University of California, Berkeley (2012) BA | Economics.

Daniel C. Fu is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2025. Published career chronology (historical appointments): Maplelane Capital (2024 - 2025) New York, NY | Senior Analyst Wafra (2019 - 2024) New York, NY | Director, Portfolio Manager Maplelane Capital (2015 - 2019) New York, NY | Senior Analyst Calamos Advisors (2012 - 2015) New York, NY | Vice President, Co-Portfolio Manager Citigroup (2006 - 2011) New York, NY | Equity Research Analyst Thomas Weisel Partners (2004 - 2006) New York, NY | Equity Research Associate. Education: The University of Pennsylvania (2004) BS | Economics.

Han Du is currently Sr. Research Associate in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2020. Published career chronology (historical appointments): Sands Capital (2020 - 2022) Arlington, VA | Research Associate. Education: University of Virginia (2020) BS | McIntire School of Commerce.

Emmanuel Schellekens is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Olivier Masson is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Laurent Levaux is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Pierre-Yves Karlshausen is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Xavier Goebels is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Christophe Fruytier is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Jacques Defer is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Benoit Coppée is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Fabian Collard is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Pierre Bernes is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Vincent Berghmans is publicly named by ORSA Fund (formerly Investsud) as Board Director. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Laurence Calozet is publicly named by ORSA Fund (formerly Investsud) as Vice-Chair of the Board. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Brian J. Crofton is currently Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2020 - 2022) Arlington, VA | Sr. Research Associate Sands Capital (2018 - 2020) Arlington, VA | Research Associate Sands Capital (2017 - 2018) Arlington, VA | Sr. Associate, Planning and Analytics Sands Capital (2014 - 2017) Arlington, VA | Planning and Analytics Associate. Education: Colgate University (2014) BA | Mathematical Economics.

Michael Clarke is currently Portfolio Manager Sr. Research Analyst; Managing Partner Portfolio Manager in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2011. Published career chronology (historical appointments): Sands Capital (2013 - 2016) Arlington, VA | Portfolio Manager, Research Analyst Sands Capital (2011 - 2013) Arlington, VA | Research Analyst FBR Capital Markets (2007 - 2011) Arlington, VA | Senior Associate Greenberg Traurig, LLP (2003 - 2005) Washington, DC | Case Law Manager. Education: George Washington University (2007) MBA | Finance University of Redlands (2002) BA | Business Administration and Biological Sciences.

Ian Chun is currently Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2026. Published career chronology (historical appointments): Vontobel Asset Management (2017 - 2025) New York, NY | Senior Research Analyst Bernstein Research (2013 - 2017) New York, NY | Senior Research Associate Bernstein Research (2012) New York, NY | Summer Senior Research Associate Highbridge Capital Management (2010 - 2011) New York, NY | Front Office Analyst Axiom Investment Advisors (2008 - 2010) New York, NY | Senior Quantitative Analyst. Education: Columbia University (2013) MBA | Columbia Business School University of California, Berkeley (2003) BS | Electrical Engineering and Computer Science.

Brian A. Christiansen is currently Sr. Portfolio Manager Research Analyst Executive Managing Director in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2006. Published career chronology (historical appointments): Sands Capital (2021 - 2022) Arlington, VA | Sr. Portfolio Manager, Research Analyst, Director of Stewardship, Executive Managing Director Sands Capital (2018 - 2021) Arlington, VA | Sr. Portfolio Manager, Research Analyst, Executive Managing Director Sands Capital (2012 - 2017) Arlington, VA | Portfolio Manager, Research Analyst Sands Capital (2008 - 2012) Arlington, VA | Research Analyst Sands Capital (2006 - 2008) Arlington, VA | Research Associate. Education: Yale University (2009) MBA | School of Management Yale University (2005) BA | Economics.

Matthew Buckley is currently Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2022 - 2026) Arlington, VA | Sr. Research Associate Sands Capital (2021 - 2022) Arlington, VA | Research Associate Capital One (2019 - 2020) McLean, VA | Corporate Development Senior Analyst J.P. Morgan (2018 - 2019) New York, NY | Investment Banking Analyst. Education: William & Mary (2018) BBA | Finance.

Teeja Boye is currently Portfolio Manager Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2014. Published career chronology (historical appointments): Sands Capital (2019 - 2022) Arlington, VA | Sr. Research Analyst Sands Capital (2014 - 2018) Arlington, VA | Research Analyst Sands Capital (2014) Arlington, VA | Consultant Insparo Asset Management (2008 - 2013) London, UK | Investment Analyst UBS (2006 - 2008) London, UK | Associate Analyst. Education: University of Virginia (2019) MBA | Darden School of Business London School of Economics (2006) BSc | Economics and Economic History.

Benjamin H. Betcher is currently Portfolio Manager Sr. Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: 2021. Published career chronology (historical appointments): Sands Capital (2024 - 2026) Arlington, VA | Sr. Research Analyst Sands Capital (2021 - 2023) Arlington, VA | Research Analyst Davis Advisors (2017 - 2021) New York, NY | Analyst Sanford C. Bernstein & Co. (2014 - 2017) New York, NY | Sr Research Associate Ampush (2011 - 2014) San Francisco, CA | Head of Finance. Education: Tufts University (2009) BS | Psychology.

Katherine (Okon) Bates is currently Research Analyst in Sands Capital’s published firmwide directory. The biography records joining or rejoining: Re-joined in 2012. Published career chronology (historical appointments): Sands Capital (2014 - 2019) Arlington, VA | Manager, Client Relations Sands Capital (2012 - 2014) Arlington, VA | Portfolio Communications Analyst Sands Capital (2007 - 2010) Arlington, VA | Assistant to the CEO. Education: University of Virginia (2012) MBA | Darden School of Business Lafayette College (2007) BA | Government and Law.

Françoise Jolly-de Vaucleroy is publicly named by ORSA Fund (formerly Investsud) as Chair of the Board. This is a current published governance affiliation, distinct from operating staff or a personally attributed cash investment.

Christine Xhauflaire is publicly named by ORSA Fund (formerly Investsud) as Facility Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Yannick Thomas is publicly named by ORSA Fund (formerly Investsud) as Accounting Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Bernadette Dropsy is publicly named by ORSA Fund (formerly Investsud) as Office Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Cindy Daussaint is publicly named by ORSA Fund (formerly Investsud) as Investment & Project Analyst. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Jean-Philippe Mathieu is publicly named by ORSA Fund (formerly Investsud) as Investment Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Gilles Koestel is publicly named by ORSA Fund (formerly Investsud) as Investment Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Benjamin Cupers is publicly named by ORSA Fund (formerly Investsud) as Investment Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Laurence Coulon is publicly named by ORSA Fund (formerly Investsud) as Investment Manager. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Stéphane Dantinne is publicly named by ORSA Fund (formerly Investsud) as Deputy CEO. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Philippe Degive is publicly named by ORSA Fund (formerly Investsud) as CEO. The institution provides long-term equity and quasi-equity financing to Walloon companies across industry, biotechnology and innovative technology; this affiliation is an operating role.

Lavinia Albertinazzi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Analyst (Evoluzione). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Luca Meloncelli is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Evoluzione). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Gianmarco De Pascalis is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Associate (Italia Space Venture); Associate (Evoluzione). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Stefano Polimeno is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Italia Space Venture); Partner (Boost Innovation). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Matteo Botticelli is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner e Responsabile del Fondo (Italia Space Venture). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Nicolò Tomei is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Analyst (Rilancio). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Carlo Fava is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Rilancio). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Ludovico Arlini is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Rilancio). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Marco Marzano is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Rilancio). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Vittorio Maraghini Garrone is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Rilancio). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Caterina Siclari is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner - Responsabile del fondo (Rilancio). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Camilla De Martino is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Analyst (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Leonardo Paglino is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Analyst (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Alessandro Frasca is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Analyst (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Ludovica Dauri is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Eleonora De Riso is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Giacomo Frigo is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Luca Barrile is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Edoardo Bolognesi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Egle Andreina Rochira is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Marc Nolet de Brauwere van Steeland is a Belgian industrial and medical-device executive and a director of Synergia Medical, with his statutory directorship effective September 23, 2015 confirmed in the current Belgian register. The iSTAR Medical board biography identifies him under the shorter published name Marc Nolet de Brauwere. He became CEO of PhysIOL in 1997 when he took over the company, following positions at Petrofina in the United States and as an associate at McKinsey. He holds degrees in civil mining engineering from Université Catholique de Louvain and industrial management from Katholieke Universiteit Leuven. His authentic named iSTAR portrait is retained as a published professional image; older lists of outside directorships are not assumed to establish all current affiliations.

Listed by the Belgian officialenterprise registry as permanentrepresentative of Synergia Medical corporate director0746.945.431 fromJune5,2024. The exact officialname is preserved. No authentic primaryportrait, fullerprofessional biography or verified link to a differentperson namedEnriqueVega has been established, so those identities and personalcheck claims are not merged.

Paolo Altomare is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Christian Boon-Falleur is a Belgian industrial executive and a statutory director of Synergia Medical, effective March 1, 2019 according to the current Belgian register. His named professional biography published by Institut Thomas More describes civil mechanical engineering studies at Université Catholique de Louvain and postgraduate business studies at Katholieke Universiteit Leuven. He worked at Ackermans & Van Haaren from 1972 to 2000, directing business sectors and serving on its management committee from 1989. The biography describes subsequent company and association directorships and a managing-director affiliation with AF Compressors. Those outside positions are source-published career context; his Synergia governance role does not imply an operating employee or personal investment.

Francesco Grassi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

A current Synergia Medical director listed in the Belgian officialregistry, with director affiliation beginningNovember27,2019. Synergia announced her chair appointment inFebruary2020 and named her chair inits2022fundingrelease; the currentregistry doesnotseparatelyconfirm chairtitle. Her current ownAgileCapitalMarketsprofile identifies her as a healthcareinvestmentbankingpartner. Her genuine namedportrait is fromthat primaryemployer directory.

Stefano Molino is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner - Responsabile del Fondo (Acceleratori). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Co-founder of Synergia Medical and inventor of its NAO.VNS optoelectronic neurostimulation platform. The company’s original2018financing release and2024clinical announcement identify him directly. His current own Stimalia founder profile describes extensive neurostimulation R&D, a doctorate and technology leadership; that source supplies his authenticportrait. The present Synergia website management directory omits him, so currentSynergia operatingCTO employment is not inferred from an outside-company biography.

Nicola Tesser is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Analyst (Internazionale); Investment Analyst (VenturItaly); Investment Analyst (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Medical adviser to Synergia Medical and principal investigator in its AURORA trial atUZGent. She is a Ghent neurologist and epilepsy researcher specializing in vagus-nerve stimulation and neuromodulation, with international training atYale andStellenbosch. This clinical/advisory role is distinct from company operating employment.

Miriam Zanardi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Analyst (Internazionale); Analista (Large Ventures); Analyst (VenturItaly); Analyst (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

An independent Synergia Medical director with extensive medical-device leadership experience. His career atStJudeMedical andAbbott included international commercial leadership and neurostimulation-related acquisitions. The Belgian registry confirms his permanent-representative affiliation fromFebruary16,2021.

Manuel Scirano is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Portfolio Controller (Internazionale); Portfolio Controller (VenturItaly); Portfolio Controller (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Co-founder and current board director of Synergia Medical. He led the company as chief executive throughJanuary2025, then CharlesNolet succeeded him onFebruary1,2025. His background includes UCLouvain business/engineering and CEMS management qualifications, technology entrepreneurship, sales and business development.

Maria Lina Costanzo is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Internazionale); Investment Manager (VenturItaly); Investment Manager (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

A Synergia Medical board director with experience in corporate finance, investment banking and medtech business development. He founded Lumine Capital Advisors in2017 after roles atPwC/Degroof and holds a Solvay business-engineering degree and CFA qualification.

Giulia Vianello is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Internazionale); Investment Manager (VenturItaly); Investment Manager (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Directs clinical development at Synergia Medical and helped lead NAO.VNS through preclinical development and its first-in-human study. She combines a bioengineering qualification with a UCLouvain doctorate in biomedical sciences and experience developing active implantable devices.

Chief financial officer of Synergia Medical. His career focuses on financial planning, growth strategy, grants and fundraising for early-stage and expanding businesses in Europe and the UnitedStates, including management of complex R&D programmes.

Chief operating officer of Synergia Medical, appointed inNovember2022. His prior operations career includes DePuy Spine, Synthes, Biwi and iSTAR Medical, covering manufacturing, engineering, procurement, quality and supply chains. He studied electronics and physics inNeuchâtel and is a SixSigmaBlackBelt.

Daniele Bertinelli is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Internazionale); Senior Investment Manager (VenturItaly); Senior Investment Manager (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Leads clinical affairs at Synergia Medical. A Leuven-trained physician with surgical training, he has worked in medical affairs and device development across preclinical research, regulatory-stage clinical programmes and postmarket requirements.

Leads quality assurance and regulatory affairs at Synergia Medical. His medical-device career spans Miracor, Vancive, Terumo Europe and IBA, including regulatory work on active implantable and other ClassIII/IIb devices and quality-system certification.

Andrea Caddeo is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Advisor (Internazionale); Senior Advisor (VenturItaly); Senior Advisor (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Chief executive of Synergia Medical fromFebruary1,2025, previously its chief strategy officer. His earlier career includes investment work at Lumine Capital Advisors and consulting at McKinsey. He studied civil engineering at UCLouvain and holds an MIT Sloan MBA focused on medtech, private equity and analytics.

Roberto Parrella is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner (Internazionale); Senior Partner (VenturItaly); Senior Partner - Co-Responsabile del Fondo (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Simona Corno is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner (Internazionale); Senior Partner (VenturItaly); Senior Partner - Co-Responsabile del Fondo (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Giacomo Valentini is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner - Responsabile del Fondo (Internazionale); Senior Partner (VenturItaly); Senior Partner (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Silvana Fumo is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Analyst (Green Transition). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Beatrice Felline is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Green Transition); Associate (Digital Transition). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Silvia Costantino is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Associate (Green Transition). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Alfonso Sessa is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Green Transition). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Enrico Filì is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile del Fondo (Green Transition); Responsabile del Fondo (Digital Transition). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Pietro Edoardo Di Bona is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Nadia Pettinari is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Marco Riccio is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Francesco Cuzzocrea is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Corporate Partners I); Investment Manager (Green Transition). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Marco Poggetti is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Gregorio Rodriguez D’acri is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Jacopo Carlo Maria Zaffaroni is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Claudio Bruno is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile del Fondo CPI - Infratech (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Stefano Piva is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile del Fondo CPI - Energytech (Corporate Partners I); Partner (Green Transition). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Francesco Mezzina is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile del Fondo CPI - Industrytech (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Laura Scaramella is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile del Fondo CPI - Servicetech (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Francesco Montanaro is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Italia Venture I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Margherita Russo is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Associate (Italia Venture I); Associate (Corporate Partners I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Hagaj Badash is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Italia Venture I); Senior Investment Manager (Italia Venture II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Svetlana Vashkel is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Italia Venture I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Dario Di Lorenzo is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Italia Venture I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Gianluigi Baldini is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner - Responsabile del Fondo (Italia Venture I). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Nicole Testa is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Analyst (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Giovanni Colombo is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Analyst (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Riccardo Romanzi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Investment Manager (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Laura Pirruccio is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Investment Manager (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Francesco Rossi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Davide Santi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Rita Verderosa is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Partner (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Claudia Pingue is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Senior Partner Responsabile del Fondo (Technology Transfer). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Alessandro Scortecci is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Direttore Investimenti Diretti. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Umberto Rosini is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile ICT. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Daniele Lattanzi is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile Risorse Umane Organizzazione e Operations. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Standing Statutory Auditor at Vertis, an accountant and statutory auditor advising on business and internationalisation at Grimaldi Studio Legale. Previously worked at Studio Associato Pellone and Tax & Advise on reorganisations and corporate transactions. Studied business economics at Naples Federico II and corporate finance and banking at Il Sole 24 Ore Business School.

Standing Statutory Auditor at Vertis and Partner at BDO Italia. Previously worked at PwC and Italaudit, with expertise in audit, compliance and accounting organisation for companies and banking groups. Studied economics at LUISS and has taught professional accounting and audit courses.

Chair of the Board of Statutory Auditors at Vertis. Former PwC senior partner responsible for audit in Central and Southern Italy, with extensive financial-reporting and accounting-organisation experience. Has taught at Naples Federico II, Naples Parthenope and LUISS, and is an accountant and statutory auditor.

Independent Director at Vertis SGR and Partner at Pirola Pennuto Zei & Associati. An accountant and statutory auditor with corporate, tax and accounting advisory experience and earlier audit work at PwC. Studied economics at LUISS.

Board director of Vertis, serving in 2008–2021 and reappointed from 2022. Entrepreneur and family-group executive with activities in construction, property, leisure marine, hospitality and catering. Holds leadership roles at Dielle, LDB, Sinergie Immobiliari, Drav and Fiart; studied economics at Naples Federico II.

Independent Chair of Vertis SGR. Professor of Financial Intermediaries at Naples Federico II, with academic and executive-education work in finance and retirement provision. Has served on bank statutory-audit and oversight bodies, chaired a university staff pension fund and serves on the board of MEFOP.

Back-office Assistant at Vertis, supporting its administration function and organisational activities. Previously worked in e-commerce businesses and business-consulting practices in administrative and accounting support. Studied communication and information science at Naples Suor Orsola Benincasa.

Head of IT at Vertis, responsible for stable, secure and efficient technology infrastructure. A certified senior systems specialist with experience in hardware, software, cybersecurity and system-performance management. Studied computing at the University of Salerno and completed professional certifications.

Compliance and Anti-Money Laundering professional at Vertis. Previously worked at the EY legal and tax practice and in BDO risk and compliance advisory. Studied economics and business management at LUISS and qualified as an accountant.

Head of Anti-Money Laundering at Vertis since May 2025 and also listed as an independent board director. Previously chaired its board and board of statutory auditors; earlier management experience includes Eni, Generali and UniCredit. An accountant and statutory auditor educated at Roma La Sapienza, with governance and internal-control responsibilities.

Head of Compliance at Vertis, with legal and financial-regulation experience. Founded ALMA – Led STA and previously led banking and financial regulation at Orrick, following work at DLA Piper and Gianni Origoni. His career includes Bank of Italy-appointed financial-intermediary oversight and teaching in financial markets.

Intern Analyst in the Vertis venture-capital division, working on sourcing, analysis and investment evaluation. Previously interned at Scientifica Venture Capital and worked at Deutsche Bank and Findomestic. Studied economics, finance and markets at the University of Campania and completed investment-analysis studies at UniVertis.

Investment Analyst at Vertis, sourcing opportunities and analysing investment dossiers. Previously completed a financial-consultant internship at UniCredit Direct. Studied business economics at Naples Parthenope and private-equity and venture-capital analysis at UniVertis.

Senior Analyst and ESG professional at Vertis, sourcing and evaluating investments and monitoring scaleup-fund portfolio companies. Previously worked in finance and performance at Deloitte. Studied economics at Naples Parthenope and accounting and management control at IPE Business School.

Investment Associate at Vertis, working on opportunity sourcing, investment analysis, digital-fund deal flow and portfolio monitoring. Studied business economics at Naples Federico II and completed accounting and management-control studies at IPE Business School.

Investment Manager at Vertis. Previously supported startup fundraising at corporate-finance boutique Volano and worked in risk-management consulting at PwC. Studied business economics at Naples Federico II and advanced finance at IPE Business School.

Investment Manager at Vertis with open-innovation, technology-transfer and innovation-management experience. Previously Science Advisor to the Italian Presidency of the Council of Ministers and an organic-chemistry researcher at institutions including Cambridge and Leiden. Studied chemistry and earned a doctorate at Pavia, followed by an MBA focused on digital transformation.

Investment Manager at Vertis, previously in M&A at Grant Thornton Italia and audit at KPMG. Studied business economics at Naples Federico II and corporate economics and law at Bocconi, including study at UPEC Paris. Qualified accountant with financial-advisory experience.

Scaleup-fund Partner and investment-committee member for Vertis Venture 2, 4 and 5. Previously founded and led WithFounders and co-founded Jobrapido, with earlier roles at Henkel, Johnson Wax, Barilla and Buongiorno Vitaminic. Holds an economics degree from Naples Federico II.

Technology-transfer Partner at Vertis, member of the Vertis Venture 3 investment committee and Managing Partner at Obloo. Previously Chief Investment & Technology Officer at TTVenture and Investment Director at Vertis, following industrial R&D work at Pirelli and Ideal Standard. Studied aeronautical engineering at Politecnico di Milano, earned an MBA at Bocconi and a doctorate at Aston Business School.

Scaleup-fund Partner and investment-committee member for Vertis Venture 2, 4 and 5. Previously worked at Opera SGR, GE Capital Interbanca in corporate finance and Deloitte in financial services. Holds a business-economics degree from Bocconi.

Digital-fund Partner and board director at Vertis SGR, with investment-committee roles for Vertis Venture 6 and 7. Previously worked in transaction advisory at EY, at L.E.K. Consulting and at BlueGem Capital Partners. Studied business economics at Naples Federico II and qualified as an accountant and statutory auditor.

Partner for Vertis Venture 8 Lazio and member of its investment committee. Founded Value Creation Team and holds leadership roles at Open Advisory, Open Venture and Cedel-Elis. Her prior executive career includes Canepa, Retelit, E-Care, FIGC and Procter & Gamble; educated at Roma La Sapienza with marketing studies at Cambridge.

Digital-fund Partner at Vertis and investment-committee member for Vertis Venture 6 Digital Sud and Vertis Venture 7 Digital Puglia. Co-founded Simbiosity and Blueshift and previously founded WithFounders. Has management-consulting and venture-capital experience and a law degree from Naples Federico II.

Co-founder of Vertis SGR in March 2007, Vice Chair and Managing Partner. Previously held management and board positions at Macrofit SIM and Borsaconsult SIM, and chaired the scouting committee of Vertis SpA. His background spans securities intermediation and industrial and services-company boards.

Founder, CEO and Managing Partner of Vertis SGR since its foundation in 2007. Previously founded Borsaconsult SIM in 1991 and Vertis SpA in 2001 after beginning his financial career as a stockbroker. His work includes university teaching in financial markets and corporate banking, and industrial and digital-company board service.

Marco Filagrana is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Direttore Rischi. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Alessandro di Gioia is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile Affari Legali, Societari e Acquisti. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Giancarlo Di Benedetto is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile Revisione Interna. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Antonio Crisafulli is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Responsabile Amministrazione, Finanza & Controllo. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Patrizia Carrarini is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Direttore Corporate Affairs. This is a corporate management responsibility within the Italian venture manager, which operates direct funds and funds of funds to support innovative businesses. Appointment dates and education are not inferred where unpublished.

Cristina Bini is a published team member of CDP Venture Capital SGR S.p.A. The current native directory lists Direttore Investimenti Indiretti; Senior Partner (Internazionale); Direttrice Investimenti Indiretti - Responsabile del Fondo (VenturItaly); Senior Partner (Multicomparto VenturItaly II). The named fund affiliations are investment-team responsibilities within the Italian venture manager, which supports technology commercialization and innovative startups through direct funds and funds of funds. Appointment dates and education are not inferred where unpublished.

Peter Seiler is publicly named in the current Belgian official registry as a statutory permanent representative on the Newton Biocapital fund board. This is a specifically qualified fund-governance affiliation rather than an operating investment-team employee or a personal cash check. Newton Biocapital publicly documents this person as Statutory Permanent Representative — Fund II. The affiliation is scoped to the published role, with no personal cash investment inferred.

Sophie Sauvage is publicly named in the current Belgian official registry as a statutory permanent representative on the Newton Biocapital fund board. This is a specifically qualified fund-governance affiliation rather than an operating investment-team employee or a personal cash check. Newton Biocapital publicly documents this person as Statutory Permanent Representative — Fund I; Statutory Permanent Representative — Fund II. The affiliation is scoped to the published role, with no personal cash investment inferred. Sophie Sauvage is an investment manager in the Q4 2024 WE Life Sciences roster since 2020. Previously worked in corporate finance, auditing and M&A in Luxembourg; holds a HEC-ULiège business-administration degree. The dated public roster does not by itself establish a new employment start day or uninterrupted tenure through October 2026.

Goro was a very successful Venture Capitalist in the life sciences – a real pioneer in his time. Some of his most notable achievements took place at Sofinnova Ventures (CA) and during his 10 years at FinTech Global Capital. He was the first Japanese National to have been selected by the Kauffman Fellow Program. Goro founded Newton Biocapital together with Alain Parthoens in early 2017, before passing away unexpectedly in December 2018. He is sorely missed by many. Newton Biocapital publicly documents this person as Co-founder (historical; deceased December2018). The affiliation is scoped to the published role, with no personal cash investment inferred.

Jean-Claude Deschamps has substantial experience in both industry and venture capital. With a background in engineering, he has been instrumental in the founding of several internationally recognized projects and institutes, including the Belgian R&D hub IMEC. Based in Belgium and Japan Newton Biocapital publicly documents this person as Chairman Emeritus and Advisor to the Board of NBC I and NBC II. The affiliation is scoped to the published role, with no personal cash investment inferred.

Jean Combalbert is an Independent Director publicly listed by Newton Biocapital. Newton Biocapital publicly documents this person as Independent Director. The affiliation is scoped to the published role, with no personal cash investment inferred.

Dirk Boogmans has extensive experience in both industry and finance. He was CEO of industrial group CFE, CEO and director of GIMV, and chairman of the Flemish Advisory Council for Innovation and Enterprise (VARIO). He has been a member of the Board of Directors at BNP Paribas Fortis since 2009, in addition to acting as a chairman for multiple companies and institutes. Based in Belgium Newton Biocapital publicly documents this person as Vice-Chairman and Chairman of the Audit Committee of NBC I and NBC II. The affiliation is scoped to the published role, with no personal cash investment inferred.

Ajit Shetty has achieved many successes in the pharmaceutical and biotechnology industries. He was CEO and Chairman of Janssen Pharmaceutica, and head of enterprise supply chain at Johnson & Johnson. Today, he continues to hold an active role in the biotech sector as Chairman of the Board of Directors of the Flemish Institute for Biotechnology (VIB) as well as multiple companies and institutes. Based in Belgium Newton Biocapital publicly documents this person as Chairman of the Board of NBC I and NBC II. The affiliation is scoped to the published role, with no personal cash investment inferred.

Toko worked at the major hospital in Tokyo as a healthcare social worker for 12 years, where she grew skilled in listening patiently, thinking critically, and solving problems. From 2012, She worked in an educational institution in Brussels. She participated in the task force for diverse learning architecture for foreign pupils while studying a postgraduate course in education for a broader perspective on communication skills. Based on these experiences, she became good at analyzing situations and optimizing procedures for a smoother office business. Toko fulfills administrative and secretarial functions to meet the Newton’s objectives and team members’ needs. Based in Belgium LinkedIn Newton Biocapital publicly documents this person as Assistant to the CEO / Office Manager / (Brussels Office). The affiliation is scoped to the published role, with no personal cash investment inferred.

Daisuke Morishita, Ph.D. (University of Tokyo), specializes in drug discovery science and oncology. After conducting drug discovery research at Takeda and Harvard, he co-founded Chordia Therapeutics in 2017 and played a pivotal role in the company’s listing on the Tokyo Stock Exchange Growth Market. He has been recognized with major national honors for venture creation and innovation in 2022 and 2024. In academia, he concurrently serves as a Visiting Professor at Nagoya City University, Kumamoto University, and Oita University, and as a Councilor of a leading Japanese oncology society. LinkedIn Newton Biocapital publicly documents this person as Venture Partner. The affiliation is scoped to the published role, with no personal cash investment inferred.

Dario has been active in IT more than 35 years and acquired expertise in Data Management, developed on multiple international projects. He has business knowledge in various sectors: insurance (12 years), chemical/pharmacy (21 years) & distribution/Logistic (4 years). Dario graduated in Computer Sciences in 1979 at the UCL/PL and obtained an Executive Master in Management in 1994 from Solvay Business School (SBS/ULB). Based in Belgium LinkedIn Newton Biocapital publicly documents this person as Chief Financial Officer. The affiliation is scoped to the published role, with no personal cash investment inferred.

Danny started technology innovation management for a Belgian multinational in 1999, where his passion for developing technology into products led to positions in market and business innovation. In 2010, Danny became responsible for managing Venture Capital investments in technology funds and start-ups in Europe, North America, and China. From 2012, as investment manager for Qbic, Danny experienced the journey of value creation from young start-up to mature acquisition target. He holds an engineering degree in materials science and a PhD in Applied Sciences. Based in Belgium LinkedIn Newton Biocapital publicly documents this person as Chief Operating Officer. The affiliation is scoped to the published role, with no personal cash investment inferred.

Michihiko Wada is a medical doctor (MD–PhD from Kyoto University), specializes in surgery, oncology, immunology, and rare diseases. After serving as Chief of Surgery at Kobe City Medical Center Chuo Municipal Hospital, he served as Head of Oncology, Specialty Medicine, Clinical Development Division of Bayer Yakuhin, and VP and Head of R&D Division of Alexion Pharma, LLC. Currently, he is a specially appointed professor at the Center for the Advancement of Clinical Research, Keio University Hospital. Based in Japan Newton Biocapital publicly documents this person as Chief Regulatory and Development Officer. The affiliation is scoped to the published role, with no personal cash investment inferred.

Graduated as MD in 1970 from Liège University (Belgium), Guy is Internal Medicine specialist with experience in immunology and rheumatology. He has extensive experience in clinical development, trial design, and strategic and translational evaluations. Guy joined Pfizer International as International Medical Director in 1982, with assignments in Brussels, New-York, and Zurich, then continued as Regional Medical Monitor in Europe from 2011 to 2014. He was Chief Clinical and Regulatory for Bone Therapeutics up to 2017. Based in Belgium LinkedIn Newton Biocapital publicly documents this person as Chief Medical and Regulatory Officer. The affiliation is scoped to the published role, with no personal cash investment inferred. Historical Neuvasq affiliation: Guy Heynen, MD, graduated from Université de Liège (Belgium) in 1970 with a degree in Medicine. He is an Internal Medicine specialist with expertise in immunology and rheumatology. Guy has extensive expertise in clinical development, trial design, strategic evaluations, and translational evaluations. He started his career with Pfizer International in 1982 as an International Medical Director and served in various assignments in Brussels, New York, and Zurich. Later, from 2011 to 2014, he worked as a Regional Medical Monitor in Europe. Guy then went on to become the Chief Clinical and Regulatory for Bone Therapeutics up until 2017.

Sada has a wealth of over 40 years of experience in life sciences businesses, and a long track record in general management at multinational corporations (including Kyowa Kirin, Baxter, Alcon, Affymetrix, Bio-Rad, and Cepheid). With extensive experience in international and cross-cultural business, Sada contributes to Newton’s successful investments of by leveraging his extensive business network built through his education and career. He holds a B.A. in Law from Waseda University (Tokyo, Japan), earned a M.B.A. from J.L. Kellogg Graduate School of Management, Northwestern University (Evanston, Illinois, USA). Based in Japan LinkedIn Newton Biocapital publicly documents this person as Japan Representative. The affiliation is scoped to the published role, with no personal cash investment inferred.

Alain has 20 years international experience in food and biotech industry as well as 20 years in venture capital. He has been a lead investor for many investments in early and neglected late-stage companies that he then brought through to an IPO or M&A transaction, including Ogeda (sold to Astellas for EUR 800 million). Based in Belgium Newton Biocapital publicly documents this person as Chief Executive Officer; Co-founder. The affiliation is scoped to the published role, with no personal cash investment inferred.

Manish Kumar Mital is historically documented as Braidwell COO and general counsel in Harvard Law School’s2022–2023 visiting-faculty publication and signed issuer agreements through2025. The Harvard publication identifies his lecturer appointment and hedge/private-equity fund law course and supplies an authentic named portrait. Current2026 FormD related-person rosters omit him; this affiliation is historical/source-qualified rather than an assertion of current employment. A precise departure date remains unverified.

Ken Joseph signs Braidwell LP’s latest September22,2026 FormADV as Chief Compliance Officer, with the same public manager role appearing in2026 SEC holdings-report signatures. This record concerns the named Braidwell compliance official; it does not merge a same-name Kroll executive, infer an outsourced employment arrangement, or attach an unverified portrait or academic biography.

Michael Metschl’s own professional profile identifies current Braidwell affiliation and University of Notre Dame education with summa cum laude distinction. His public activity connects to the firm’s health and AI-enabled biotechnology investment discussions. Exact current rank and any lead-therapeutics title appear only in third-party directories reviewed and are not asserted as independently verified; same-name German engineering professionals are kept separate.

Kaila Krum is a publicly affiliated Braidwell investor whose own profile and manager-reposted2026 healthcare capital-market panel statement document work with medtech and diagnostics companies. Her self-published profile names University of Iowa education and securities research/registration qualifications. Primary evidence supports the investment-team affiliation; an exact partner title, employment start day or personal investment is not inferred from third-party staff directories.

Narendra Nayak is publicly affiliated with Braidwell on his own professional profile and featured by the manager’s news feed. The manager’s own2026 public post identifies his participation alongside Kaila Krum in healthcare capital-market/medtech discussions; his first-person statements identify Braidwell’s Impulse Dynamics and Alamar partnerships. His profile reports UCLA Anderson education. Exact current title and full career biography remain unpublished in the primary sources reviewed; third-party partner labels are not silently promoted to verified current titles.

Ilan Sender is identified as a Braidwell partner in Caris’s January2023 actual debt-financing release and remains an own-manager featured author in2026. His first-person June2025 Caris IPO post describes Braidwell’s earlier non-dilutive and hybrid financing partnership. The role title is source-qualified to the published issuer biography; the IPO post is not proof of a fresh IPO allocation or personal check.

Sommer Chatwin leads Business Systems as a Braidwell partner, according to her current Life Science Cares adviser biography. It describes earlier Bridgewater chief-of-staff work for its COO and roles in the chairman’s office, client service/research and executive recruiting. She co-founded NeighborShare and holds a Towson economics degree. The association’s exact named portrait and substantive biography support identity; unrelated nonprofit roles are not buyer checks.

Nick Myerberg is Braidwell’s partner and head of artificial intelligence and technology, expressly identified in its own2026 publications. His primary public discussion focuses on AI-native drug discovery, scientific reasoning systems, proprietary data and integrated experimental learning loops. His exact named GEM workshop portrait is authentic. Workshop sponsorship, a research interview or praise of a company does not establish an additional investment.

Colin Bettison is a named Braidwell financial executive. February5,2026 Partners fund FormD identifies him as CFO, and September22,2026 LabsPortfolioII filing identifies him as CFO of that fund’s general partner. Earlier signed investment agreements describe Head of Finance and Operations. These are scoped filing-specific titles rather than an invented founder role or personal cash check; latest public signature confirms active2026 affiliation.

Brian Kreiter, legally Brian James Kreiter in SEC filings, co-founded Braidwell in2021 and serves as CEO and partner. His own biography describes previous Bridgewater COO, board and client-service/investment-research leadership, following McKinsey consulting. He co-founded the poverty-focused nonprofit LIFT in1998 and NeighborShare in2020. He holds Yale and Harvard Business School degrees. These nonprofit and corporate leadership backgrounds do not themselves prove personal investments.

Alex Karnal, legally Alexander Thomas Karnal in SEC filings, co-founded Braidwell in2021 and leads its investment team as CIO and partner. His own biography describes Deerfield partnership/managing-director and co-portfolio-manager work from2005–2021, helping establish its healthcare innovation campus. He co-founded the nonprofit Institute for Life Changing Medicines and earlier worked in Merrill Lynch equity-linked products/capital markets. He holds MIT and Johns Hopkins science degrees. SEC2026 confirms the same founder/legal identity; no personal portfolio check is inferred.

Yogesh Kamra is Head of Lab Operations (UK site) in IlluminaVentures currentownpublicdirectory. Yogesh provides operational and scientific support to startups at Illumina Ventures Labs UK, ensuring that Illumina Ventures Labs companies can focus on advancing their technologies in a reliable and well-supported environment. Drawing on over 14 years of experience in molecular biology and genomics, Yogesh works closely with startup teams to implement scalable workflows and maintain high performing lab operations. Before joining Illumina Ventures Labs in 2025, Yogesh was a Senior Scientist at BenevolentAI, where he developed automated RNA sequencing workflows in support of AI-driven drug discovery programs. He previously held scientific roles at Quell Therapeutics, NHS Genomics Core and King’s College London, contributing to assay development, biomarker discovery and immune monitoring across translational and clinical research programs. Throughout his career, Yogesh has authored 13 peer-reviewed publications including some in Nature Communications and Journal of Experimental Medicine highlighting his research in immunology, genomics and transplant biology. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Wouter Meuleman is Partner in IlluminaVentures currentownpublicdirectory. Wouter was part of the founding team at Illumina Ventures and brings more than 20 years of experience in life sciences tools development and genomics to the fund. Previously, he was director of Corporate Development at Illumina, where he led investments including Desktop Genetics (acquired by Celixir in 2018). Wouter also held senior roles in Research and Development (R&D) and Product Development at Illumina, and was instrumental in the development of sequencing platforms, the sourcing and evaluation of new technology opportunities, and competitive benchmarking. An electrochemist by training, Wouter made his debut in life sciences in 2003 as first hire for Oxford University spin-out Oxamer, a company founded by Lasker-award winner professor Sir Edwin Southern, where he contributed to the development of a benchtop DNA microarray fabrication platform. Following the company’s merger with Oxford Gene Technology (later acquired by Sysmex), he continued working alongside Prof. Southern, leading R&D on single cell gene expression analysis and novel applications for DNA microarrays. Wouter obtained a joint Bachelor and Master of Science (magna cum laude) in Chemistry from Ghent University, Belgium; a Ph.D. in Chemical Engineering from Newcastle University, UK; a Master of Business Administration from the University of Cambridge’s Judge Business School; and is a Kauffman Fellow. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

William Byrne is Senior Associate in IlluminaVentures currentownpublicdirectory. William is based in Ireland and previously, was head of Biotechnology at NEOM, a greenfield city under construction in Saudi Arabia. During his time at NEOM, William determined the scientific focus areas and advanced the core enablers (regulations, infrastructure, funding and talent) necessary to stand up the biotech industry. He also defined NEOM’s offering in the multi-omics space. Prior to joining NEOM, William worked in strategy consulting in the Middle East and Europe, where he advised a broad range of clients in the healthcare and life sciences industries. For these clients, he delivered investment, research, go-to-market and product launch strategies. William also worked at a biotech start-up seeking to commercialize bacterial gene therapy. William earned a PhD in Cancer Immunology and a Bachelor of Pharmacy from University College Cork, Ireland. He also holds a Master of Business Administration from INSEAD, France. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Tom Willis is Venture Partner in IlluminaVentures currentownpublicdirectory. Tom joined Arima Genomics as its CEO in June 2025. Arima is dedicated to transforming cancer diagnosis and therapy selection through its proprietary platform to reveal otherwise unmeasurable structural mutations. Tom has been an entrepreneur in the genomics industry for the past 20 years, during which time he founded and successfully exited two startups in the genomic tools and diagnostic space. Early in his career, Tom directed technology development efforts at the Stanford Genome Technology Center during the human genome project. He left Stanford in 2001 to found his first venture, ParAllele BioScience, where he served as the founding CEO. After two rounds of venture financing and the successful development and commercialization of high throughput genotyping tools, ParAllele was acquired by Affymetrix in 2005. Tom founded his second venture, Sequenta in 2008. As CEO, he and his team developed and commercialized a sequencing-based platform for the assessment of the human immune repertoire. ClonoSEQ, the lead diagnostic indication, enables the assessment of residual disease in leukemia and lymphoma. This technology has been widely adopted by major cancer centers and established as the standard of care in the National Comprehensive Cancer Network (NCCN) guidelines. In 2015 Sequenta merged with Adaptive Biotechnologies to build a public immune platform company. Tom received his Ph.D. in Physics from Stanford University after earning a Bachelor of Science in Physics from Yale University. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Timothy Stenzel is Advisor in IlluminaVentures currentownpublicdirectory. Throughout his career as an executive leader with deep scientific expertise, Tim has helped many organizations create and launch innovative products and services that form new lines of business driving high revenue growth. Tim is the former director of the US Food and Drug Administration’s (FDA) Office of In Vitro Diagnostics and has an extensive scientific background in molecular diagnostics, genetics, oncology and infectious diseases. During his five-year tenure at the FDA, he led a team of almost 300 scientists and was known for working with multiple constituencies to create solutions to secure patient access to reliable tests. Prior to his government service, Tim held leadership roles in both industry and academia. As the chief operating officer of Invivoscribe, he helped to launch more than 22 new products and services, including an FDA-approved companion diagnostic for Novartis’ drug Rydapt (midostaurin). While serving as the chief scientific officer of Quidel Corporation, he led the creation of their molecular diagnostics franchise, which now has more than 23 cleared products with significant revenue. Tim also served on the Duke University School of Medicine faculty for 21 years and founded its Clinical Molecular Diagnostics laboratory. Tim earned his Bachelor of Arts in Chemistry with honors from Grinnell College and his MD and PhD in Microbiology and Immunology from Duke University. He was board certified in Pathology and Clinical Molecular Genetics following his residency and fellowship at Duke. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Shalaka Wahane is Lead Scientist, Head of Lab Operations (US site) in IlluminaVentures currentownpublicdirectory. Shalaka provides technology expertise and scientific direction to incoming genomic startups in the San Francisco Bay Area. Prior to joining Illumina Ventures in 2023, she was a staff scientist for Seed Investments and Technology at Illumina, where she oversaw the development and operations for the Illumina Accelerator program, which was the foundation for Illumina Ventures Labs. This program for seed stage companies helped launch 74 companies and attracted more than $1.2B in third party investments over 15 funding cycles. Previously, Shalaka worked as an assistant project scientist at the University of California, Los Angeles in the labs of Drs. Michael Sofroniew and Daniel C. Lu, where she led preclinical studies in ALS, utilizing her deep expertise in neurodevelopment, central nervous system inflammation and neurodegeneration. Shalaka earned her PhD in Developmental Neurobiology from the University of Freiburg, Germany and continued her scientific career with postdoctoral work at the Icahn School of Medicine at Mount Sinai, New York. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Rose Lai is Senior Executive Assistant in IlluminaVentures currentownpublicdirectory. Rose is the senior executive assistant to Illumina Ventures founder, Nick Naclerio, PhD, and is also the company’s co-office manager. She started as an assistant in Research at Piper Jaffray and continued to build her career as an executive assistant at investment banks Seven Hills Group and GCA Savvian prior to joining Illumina Ventures. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Ronan Byrne is Venture Advisor in IlluminaVentures currentownpublicdirectory. Ronan is a CEO and commercial leader with more than two decades of experience building several companies and selling them to large multinationals. His early career included Beverly Records Management, which was sold to Iron Mountain (NYSE: IRM) and Engage Technologies, sold to Northgate Plc (FTSE 250). Over the past ten years, his focus has been on the commercialization of innovations in life sciences. He was CEO and co-founder of ClearSight Innovations, ophthalmic diagnostic technologies, which successfully exited to an industry leader. Ronan was also involved in the early development of Genomics Medicine Ireland and is currently leading an emerging spin-out company, Pharma Latch, which is focused on intradermal delivery for drugs, vaccines and a range of immunotherapies. He acts as an evaluator, panelist and mentor for organizations such as Enterprise Ireland. He has also mentored a wide range of life sciences companies spanning digital health, devices, genomics, pharma and drug delivery. Ronan holds a bachelor’s degree in Economics and Politics from University College Dublin, as well as a Master of Business Administration from University College, Dublin, Michael Smurfit Business School. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Natalie Nakamoto is Executive Assistant, Office Manager in IlluminaVentures currentownpublicdirectory. Natalie supports the team at Illumina Ventures and also co-manages the day-to-day activities of the office. She started her career in Customer Service & Support at Bank of America and advanced to administrative assistant in the Premier Banking & Investments and Consumer Banking departments. Natalie has an associate’s degree in Business Administration and Software Technology from Heald College in California. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Martin Moorhead is Chief AI Scientist in IlluminaVentures currentownpublicdirectory. Martin is a scientific entrepreneur with 25 years of experience in therapeutics, diagnostics and omics tools companies. He combines a deep background in AI, machine learning, computational biology, and statistics with expertise in biology, biochemistry and genomics. Prior to joining Illumina Ventures, Martin was chief technology officer at Encoded Therapeutics and senior vice president of Research and Development at Adaptive Technologies. Previous companies include Sequenta, Affymetrix and ParAllele Biosciences. He has contributed to more then 40 peer-reviewed papers and has expertise in viral vectors, machine learning and assay development. Martin earned his PhD in Particle Astrophysics as Oxford University and his Master of Science in Computer Science at Imperial College, London. He was a postdoctoral fellow at Oxford and later at Lawrence Berkeley National Lab, followed by a Temporary University Lectureship (assistance professor) at Oxford. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Mara Aspinall is Partner in IlluminaVentures currentownpublicdirectory. Mara is a healthcare industry pioneer with deep experience in leading genetics, genomics and diagnostics companies and commitment to civic involvement. Mara was president and CEO of Ventana Medical Systems, a billion-dollar division of The Roche Group, (now Roche Tissue Diagnostics). She led her world-class team to new financial success, more than two dozen major instrument and assay launches, as well as global leadership in companion diagnostics. Mara spent 13 years at Genzyme Corporation, as president of Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics was a leading provider of diagnostic testing and genetic counseling in the oncology and reproductive markets. She transformed the business from a small, specialized player to one of the top five laboratories in the US while setting the industry standard for quality testing. The business was sold to LabCorp for $1 billion. Previously, Mara led Genzyme Pharmaceuticals and its transformation to an international leader in specialized pharmaceutical ingredient manufacturing. Mara also has strong VC expertise co-founded BlueStone Venture Partners with a robust portfolio of diagnostic, medical device and digital health companies. She has a passion for education, publishing the popular Sensitive and Specific: The Testing Newsletter and the annual Health Catalysts Diagnostics Year in Review. This commitment to expanding knowledge drove her to create the Biomedical Diagnostics master’s degree program at Arizona State University, the only program dedicated exclusively to diagnostics and genomics. During the pandemic, Aspinall emerged as a national authority on COVID testing. She was the principal investigator at ASU on The Rockefeller Foundation grants - creating TestingCommons.com and EvidenceCommons.com - Internationally recognized interactive databases on COVID tests. Mara was named Arizona Biosciences Leader of the Year by the Arizona Biotechnology Association and one of the “100 Most Inspiring People in Life Sciences” by PharmaVOICE magazine. She holds a Master of Business Administration from Harvard Business School, a Bachelor of Arts from Tufts University, and is certified in Cybersecurity Oversight from Carnegie Mellon/National Association of Corporate Directors (NACD). Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Malek Faham is Chief Scientist in IlluminaVentures currentownpublicdirectory. Malek is an inventor and an entrepreneur. He was previously the co-founder and chief scientific officer of Sequenta, a company founded in 2008 to discover and develop diagnostic tests based on immune cell receptor repertoire sequencing. Sequenta developed and validated sensitive DNA-sequencing based minimal residual disease testing for leukemia, lymphoma and myeloma, and it was acquired by Adaptive Biotechnologies in 2015. Malek also co-founded ParAllele Biosciences in 2001 and served as its director of Research. ParAllele’s polymorphism detection and genotyping technologies were adopted by many pharmaceutical and academic partners, including the HapMap project. The company was acquired by Affymetrix for $120M in 2005, and Malek transitioned into vice president of Research and Oncology Technology where he remained until 2008. During that time, he spearheaded the development of multiple genomic technologies that combined different methods for specific highly multiplexed amplifications with array readouts. These were applied to analysis of copy number from formalin fixed samples, high resolution promoter methylation, and high throughput high accuracy array resequencing. Malek obtained a Ph.D. in Human Genetics and an MD (board eligible in Psychiatry) from the University of California, San Francisco. He has published 60 peer reviewed articles and is an inventor on 40 US issued patents. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Jessica Wong is Controller in IlluminaVentures currentownpublicdirectory. Jessica is responsible for finance, accounting and reporting of the Funds, GPs, Management Company, and affiliated Labs entities. She brings more than 15 years of private equity/venture capital accounting and tax experience to her role. Jessica was a senior auditor at Deloitte & Touche Assurance and Enterprise Risk practice with a focus in Hedge Funds and Mutual Funds. After relocating to the Bay Area, Jessica joined Silver Lake Partners, a large private equity firm with focus on leveraged buyout, as a senior fund accountant. She was responsible for accounting and financial reporting of co-investment funds and side investment funds with a $1.3 billion in AUM. Jessica later joined CM Capital Advisor as the senior investment accountant with focus on accounting and financial reporting for various Fund of Funds entities. Prior to joining Illumina Ventures, she was at Pinnacle Ventures as the accounting manager and was responsible for the accounting and financial reporting of multiple funds that focused on loan, warrant and preferred stock investments, and related GP entities. Jessica earned her Master of Science in Accounting with distinction from the McCallum Graduate School of Business at Bentley University, and graduated cum laude from Bentley University with her Bachelor of Science in Accounting. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Jerry Steiner is Advisor in IlluminaVentures currentownpublicdirectory. Jerry brings a deep understanding of the opportunities and challenges associated with using genomics to make agriculture more sustainable. Currently, Jerry serves as the executive chairman of Pluton Biosciences, an Illumina Ventures portfolio company that harnesses microbes to develop sustainable solutions for agriculture and climate, as well as a number of other private companies. In 2015, Jerry co-founded and served as the CEO of CoverCress, commercializing a new winter cash crop for Midwest farmers that protects the soil, and then led its successful sale in 2022. As the former executive vice president of Sustainability and Global Corporate Affairs for Monsanto, Jerry was part of the team that transformed Monsanto from a chemical company to an agricultural biotech company while overcoming complex regulatory, public relations and business model challenges. He also held roles as vice president of Product and Corporate Strategy and general manager in the US and Europe, as well as co-founded Field to Market, an agriculture sustainability organization. Earlier in his career, Jerry was part of the leadership team at Celera Genomics. He received a Master of Business Administration from Washington University in St. Louis after earning a Bachelor of Science in Agricultural Economics from the University of Wisconsin. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Ivan Coulter is Venture Advisor in IlluminaVentures currentownpublicdirectory. Ivan is an innovator and entrepreneur with extensive experience in translating early-stage innovations into clinical development programs. As a pharmacologist, Ivan has an appreciation of and insights into the importance of aligning molecular pathways with appropriate therapeutics and diagnostics. He was the founder of Sigmoid Pharma and the lead inventor of its advanced drug delivery technology and GI-focused applications, including target IBD therapeutics and oral vaccines. During his tenure as CEO, Sigmoid raised over €90M in equity and executed co-development licensing agreements with specialty GI companies. As a consultant, Ivan has advised academics and entrepreneurs in setting up companies, developing fundable strategies and building multidisciplinary teams. Ivan holds a Bachelor of Science in Pharmacology and a PhD in Cancer Research from University College Dublin, was a postdoctoral fellow at the Institut Curie, Paris, and received his Master of Business Administration from the Johnson Graduate School of Management at Cornell University. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Donal Delaney is Chief Financial Officer in IlluminaVentures currentownpublicdirectory. Donal’s background includes a mix of venture capital, venture debt, public accounting, corporate controller and financial systems experience. Before joining Illumina Ventures, he was chief financial officer at Pinnacle Ventures, a venture capital and venture debt firm, where he was responsible for financial reporting, fund operations and limited partners (LP) communications. Prior to that role, Donal was the corporate controller at SVB Financial Group, a financial services company focused on serving emerging, growth and established technology companies and the life sciences and private equity markets. During that time, Donal was responsible for corporate accounting, taxes and external financial reporting, including reporting to the Securities and Exchange Commission. Before joining SVB Financial Group, he was an auditor with both KPMG and Ernst & Young. Donal has a Bachelor in Management from Trinity College, Dublin, Ireland and has been a California certified public accountant (CPA) since 1997. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

David C. Duffy is Entrepreneur in Residence in IlluminaVentures currentownpublicdirectory. David is an entrepreneurial scientist who has devoted his career to the development of bioanalytical technologies and products for life science research and clinical diagnostics. He has worked to translate novel, enabling technologies from academia into start-ups, and built these companies to initial commercialization and beyond. David most recently served as CTO at Quanterix Corporation having joined the company as its second employee in 2007. At Quanterix, he led the development of the single molecule array (Simoa) technology and products that catalyzed the field of blood-based diagnosis of neurological diseases, such as Alzheimer’s disease. Prior to Quanterix, he worked as a scientist at Surface Logix, Gamera Biosciences, and Unilever. David has published more than 50 papers in the fields of microfluidics, surface chemistry, single-molecule detection, and proteomics, and is an inventor on 36 US patents. In 2023, he received the Daniel Perlman Memorial Award from the American Chemical Society for his role in establishing the field of digital immunoassays. David was a post-doctoral research fellow in the Department of Chemistry and Chemical Biology at Harvard University, and was the first Sir Alan Wilson Research Fellow of Emmanuel College at the University of Cambridge. He received his Ph.D. in Physical Chemistry from the University of Cambridge, and earned his M.A. and B.A. degrees in Natural Sciences from Selwyn College at the University of Cambridge. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Charles White is Principal in IlluminaVentures currentownpublicdirectory. Charles joined the team from Putnam Associates, where he advised biotech and pharmaceutical companies on strategic decisions, including competitive positioning,  market research, demand forecasting, and acquisitions. While pursuing his Ph.D. degree, Charles also worked with Biotech Connection Bay Area, where he coordinated networking and professional development events for graduate students and postdocs in the Bay area. Charles earned his Ph.D. from the University of California, San Francisco where he studied the biochemical mechanisms underlying age-related regenerative decline in the mammalian brain in the lab of Dr. Saul Villeda. He completed a dual Bachelor of Science in Biotechnology and Biochemistry at Worcester Polytechnic Institute in Massachusetts. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Bill Rastetter is Advisor in IlluminaVentures currentownpublicdirectory. Bill focuses on making and growing investments in biotechnology. Bill served on the board of Illumina for 17 years including 10 years as chairman and now represents Illumina as an outside director of their majority owned subsidiary GRAIL. He also serves as chairman for two San Diego companies: Neurocrine Biosciences and Fate Therapeutics. He is the lead outside director for Cerulean, and on the board of directors of Regulus. Bill is an advisor to Leerink Partners, a healthcare focused investment bank; additionally, he serves on the Board of Trustees for Caltech. He was a founder and the chairman of Receptos, which was sold to Celgene in August 2015. Bill led the “merger of equals” that formed Biogen Idec in 2003 and retired as executive chairman at the end of 2005. Bill joined Idec Pharmaceuticals at its founding in 1986 and grew it to a multibillion-dollar market valuation company, while serving as chairman and CEO. While at Idec, he was a co-inventor of Rituxan®, which became the first monoclonal antibody approved by the US Food and Drug Administration for cancer, and one of the world’s most valuable cancer therapies. Prior to Idec, he served in various capacities at Genentech. Previously, Bill held various faculty positions at the Massachusetts Institute of Technology (MIT), won the award for “Excellence in the Teaching of Chemistry” at Harvard University, and was named an Alfred P. Sloan Fellow. Bill earned his Bachelor of Science in Chemistry from MIT and his master’s degree and PhD in Chemistry from Harvard. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Abhijit Ron Mazumder is Partner in IlluminaVentures currentownpublicdirectory. Ron brings almost 30 years of experience working with biomarkers, technologies, and computational approaches for pharmaceutical and diagnostics programs. After leading the development of genomics technologies and novel platforms for several biotech companies, Ron worked for Johnson & Johnson and Merck, where he developed diagnostics and companion diagnostics, and pharmacodynamic and predictive biomarkers. Most recently, he was vice president and global head of Oncology Biomarker Development and Companion Diagnostics at Genentech. Ron obtained his bachelor’s degree from The Johns Hopkins University, his Ph.D. from the University of Maryland and his Master of Business Administration from Lehigh University in Pennsylvania. Publishedportfolioinvolvement isinstitutionalsupport anddoesnotestablishpersonal cashchecks. Externaladvisor/venturepartner classifications arekeptseparatefromcoreemployees.

Emma Mead is a neuroscience drug-discovery researcher at the University of Oxford, where primary institutional directories identify her as Chief Scientific Officer of the Alzheimer’s Research UK Oxford Drug Discovery Institute. Her own professional profile names Acionna Therapeutics, but the accessible text does not establish a precise company job title; her Oxford CSO title is not assigned to Acionna.

Wioleta Zelek is a UK Dementia Research Institute group leader at Cardiff University researching brain-penetrant complement therapeutics for neurodegenerative disease. Race Against Dementia identifies her as an Acionna Therapeutics co-founder who continues to advise the company. She trained in chemistry and later immunology; her academic lab personnel are not automatically Acionna employees.

Damhnait Roisin Nicamhlaoibh is listed by Companies House as an active director of Acionna Therapeutics Ltd, appointed April24,2025. The statutory record does not establish an operating employment title or a current portrait.

Bryan Paul Morgan, professionally B. Paul Morgan, is a UK Dementia Research Institute group leader at Cardiff University studying complement-mediated inflammation in Alzheimer’s disease. He is a statutory director of Acionna Therapeutics Ltd, appointed April24,2025. Academic research and company directorship are distinct affiliations.

James Bilsland is a statutory director of Acionna Therapeutics Ltd, UK company16309416, appointed July14,2025. His precise operating role is not established by the statutory appointment; the conference name Jamie Bilsland is retained as an unconfirmed public alias rather than merged with another person.

Dr Sylvaine Guérit is identified by Neuvasq as Head of Preclinical Research in its March 25, 2025 conference announcement and its own October 2026 EURETINA update. She presents the company’s preclinical Wnt surrogate antibody and neurovascular-barrier research; this is a research leadership role, not evidence of clinical efficacy or an approved medicine.

Richard Hugh Phillip Porter is listed by the Belgian government CBE registry as a Neuvasq Biotechnologies director since August 8, 2022, still present in the October 7, 2026 registry snapshot. The issuer’s September 15, 2022 announcement named Richard Porter, then Chief Business Officer of uniQure, as a new independent director. His name is absent from the current marketing board directory; the legal registry affiliation is retained with this discrepancy qualified.

Areas of Expertise Vascular & CNS Development, BBB Function and Dysfunction, Wnt Signaling Additional Institutions/Organizations Chair of the Scientific Advisory Board of “The International Symposium on Signal Transduction at the Blood-Brain Barriers” Country Germany

PhD, Head Discovery at Neuvasq Marc has over 20 years of experience in biotech companies, covering the field of drug discovery. He spent 14 years as head of Biochemistry and In Vitro Pharmacology at Oxurion, and 8 years at Dyax, first as Associated Director Biochemistry, and later as Manager of Operations. Marc obtained his PhD at the Université de Liège (Belgium) and worked as a post-doctoral researcher at the Université de Liège, the University of Bayreuth and St. Jude Children’s Research Hospital in Memphis TN

PhD, CEO at Neuvasq Emmanuel, ex-Vice President and Partner at UCB Ventures, has an impressive track record of sourcing and leading equity investments in companies like Esobiotec, Walden Biosciences, and Locanabio, as well as LP investments in other funds. As UCB’s Head of Business Development Neurology, he successfully executed multiple licensing agreements, product acquisitions, and equity investments in Lumos Pharma (Nasdaq : LUMO). Emmanuel also led the launch and equity financing of UCB’s spin-out Syndesi Therapeutics, which was later acquired by AbbVie, and held prior leadership positions in Sales and Global Marketing at UCB and in Gene Editing Research at Cellectis SA. Emmanuel received an MBA from IMD (Switzerland), a PhD in Molecular Biology from Université libre de Bruxelles (ULB, Belgium) based on research conducted at the European Molecular Biology Laboratory (Germany), and a MSc in Biochemistry from the Université de Liège (Belgium). He previously served on the boards of Esobiotec, Walden Biosciences, Syndesi Therapeutics (acquired by AbbVie), and as observer at Locanabio and Lumos (Nasdaq : LUMO).

Cheng Xing is a managing partner of Sherpa Healthcare Partners. He formerly served as a Legend Capital director and healthcare fund investment-committee member, with a focus on biotechnology, medical devices and services. He holds bachelor’s and master’s degrees from Peking University. Prior investment examples in his biography do not identify the exact current Sherpa fund or individual personal capital.

Xiangyu Ouyang is a managing partner of Sherpa Healthcare Partners. Previously a Legend Capital managing director from 2004 to 2017, he helped establish its dedicated healthcare team and fund. His investment focus includes medical devices and medical services. His published education comprises an EMBA from CKGSB, an engineering master’s from Tsinghua University and a bachelor’s from Wuhan University.

Kasper Jahn joined Novo Holdings in 2014 as part of the Principal Investments team, Novo Holdings’ buyout investment team focusing on healthcare. In 2021, Kasper transitioned to head the Strategy Office, and in 2025 he joined the Executive Leadership Team, also assuming responsibility for People & Organisation. Before joining Novo Holdings, Kasper was an Engagement Manager for McKinsey & Company in their Copenhagen office. During his time with McKinsey & Company, Kasper primarily served pharmaceutical and medical device companies. Kasper holds an MSc (2009) and a PhD (2011) in Nanoscience from Aarhus University, and is a CFA® Charterholder.